The James Buchanan Brady Urological Institute
 
 
 
Patrick C. Walsh, M.D, prostate cancer, radical retropubic prostatectomy, nerve sparing
Print photo (1.03 MB)
Patrick C. Walsh, M.D.
University Distinguished Service Professor of Urology
Johns Hopkins Medical Institutions

Free Access to abstracts at PubMed

PUBLICATIONS

 

  1. Walsh PC , Gittes RF. Inhibition by antiandrogens of the prostatic growth stimulated by adrenal androgens and pituitary prolactin in castrate rats. Surg Forum. 1969;20:518-9.
  2. Walsh PC , Swerdloff RS, Odell WD. Cryptorchism:effect on pituitary gonadotropin secretion in the rat. Surg Forum. 1970;21:530-2.
  3. Walsh PC , Gittes RF. Inhibition of extratesticular stimuli to prostatic growth in the castrate rat by antiandrogens. Endocrinology. 1970 Sep;87(3):624-7.
  4. Walsh PC , Gittes RF, Lecky JW. Aortography in experimental renal failure. Evaluation of contrast media toxicity. Radiology. 1970 Oct;97(1):33-7.
  5. Swerdloff RS, Walsh PC , Jacobs HS, Odell WD. Serum LH and FSH during sexual maturation in the male rat:effect of castration and cryptorchidism. Endocrinology. 1971 Jan;88(1):120-8.
  6. Walsh PC , Korenman SG. Mechanism of androgenic action:effect of specific intracellular inhibitors. J Urol. 1971 Jun;105(6):850-7.
  7. Walsh PC , Kaufman JJ, Coulson WF, Goodwin WE. Retroperitoneal lymphadenectomy for testicular tumors. JAMA. 1971 Jul 19;217(3):309-12.
  8. Walsh PC , Swerdloff RS. Testosterone:effect on rat testis. Surg Forum. 1972;23(0):522- 3.
  9. Walsh PC , Swerdloff RS, Odell WD. Cyproterone:effect on serum gonadotropins in the male. Endocrinology. 1972 Jun;90(6):1655-9.
  10. Swerdloff RS, Walsh PC , Odell WD. Control of LH and FSH secretion in the male:Evidence that aromatization of androgens to estradiol is not required for inhibition of gonadotropin secretion. Steroids. 1972 Jul;20(1):13-22.
  11. Walsh PC , Swerdloff RS. Experimental cryptorchism:effect on serum LH and FSH in the rat. Urol Res. 1973 Jan;1(1):22-6.
  12. Constantinople NL, Walsh PC . Activity of mullerian-inhibiting substance in postnatal testes. Surg Forum. 1973;24:538-9.
  13. Swerdloff RS, Walsh PC . Testosterone and oestradiol suppression of LH and FSH in adult male rats:duration of castration, duration of treatment and combined treatment. Acta Endocrinol (Copenh). 1973 May;73(1):11-21.
  14. Walsh PC , Kaufman JJ, Smith RB, Goodwin WE. Percutaneous antegrade pyelography in hydronephrosis. Preoperative assessment. Urology. 1973 Jun;1(6):537-41.
  15. Saalfeld J, Walsh PC , Goodwin WE. Ureterovaginoplasty for vaginal atresia (unique technique in treatment):a case report with description of associated arterial anomalies and retroiliac artery ureters. J Urol. 1973 Jun;109(6):1039-45.
  16. Smith RB, Walsh PC , Goodwin WE. Cyproterone acetate in the treatment of advanced carcinoma of the prostate. J Urol. 1973 Jul;110(1):106-8.
  17. Walsh PC , Swerdloff RS, Odell WD. Feedback regulation of gonadotropin secretion in men. J Urol. 1973 Jul;110(1):84-9.
  18. Khudr G, Walsh PC , Benirschke K. Quinacrine fluorescence of testicular tumors. Urology. 1973 Aug;2(2):162-4.
  19. Walsh PC , Swerdloff RS. Biphasic effect of testosterone on spermatogenesis in the rat. Invest Urol. 1973 Nov;11(3):190-3.
  20. Walsh PC , Swerdloff RS, Odell WD. Feedback control of FSH in the male:role of oestrogen. Acta Endocrinol (Copenh). 1973 Nov;74(3):449-60.
  21. Piconi JR, Henry SC, Walsh PC . Rapid development of carcinoma in diverticulum of the bladder. A pitfall in conservative management. Urology. 1973 Dec;2(6):676-7.
  22. Walsh, P.C. Antiandrogens: Mechanism of action and cliical applications. Actuelle Urologie 4:189-196, 1973.
  23. Cochran JS, Walsh PC , Porter JC, Nicholson TP, Peters PC. Clinical evaluation of human chorionic gonadotropin levels in men with testicular tumors. Surg Forum. 1974;25(0):542-3.
  24. Henry SC, Walsh PC , Rotner MB. Choriocarcinoma of the testis. J Urol. 1974 Jul;112(1):105-8.
  25. Nicholson TC, Walsh PC , Rotner MB. Lymphadenectomy combined with preoperative and postoperative cobalt 60 teletherapy in the management of embryonal carcinoma and teratocarcinoma of the testis. J Urol. 1974 Jul;112(1):109-10.
  26. Hill DR, Crews QE Jr, Walsh PC . Prostate carcinoma:radiation treatment of the primary and regional lymphatics. Cancer. 1974 Jul;34(1):156-60.
  27. Walsh PC , Madden JD, Harrod MJ, Goldstein JL, MacDonald PC, Wilson JD. Familial incomplete male pseudohermaphroditism, type 2. Decreased dihydrotestosterone formation in pseudovaginal perineoscrotal hypospadias. N Engl J Med. 1974 Oct 31;291(18):944-9.
  28. Walsh PC . Physiologic basis for hormonal theapy in carcinoma of the prostate. Urol Clin North Am. 1975 Feb;2(1):125-40.
  29. Walsh PC , Siiteri PK. Suppression of plasma androgens by spironolactone in castrated men with carcinoma of the prostate. J Urol. 1975 Aug;114(2):254-6.
  30. Cochran JS, Walsh PC , Porter JC, Nicholson TC, Madden JD, Peters PC. The endocrinology of human chorionic gonadotropin-secreting testicular tumors:new methods in diagnosis. J Urol. 1975 Oct;114(4):549-55.
  31. Madden JD, Walsh PC , MacDonald PC, Wilson JD. Clinical and endocrinologic characterization of a patients with the syndrome of incomplete testicular feminization. J Clin Endocrinol Metab. 1975 Oct;41(4):751-60.
  32. Swerdloff RS, Walsh PC . Pituitary and gonadal hormones in patients with varicocele. Fertil Steril. 1975 Oct;26(10):1006-12.
  33. Catt KJ, Dufau ML, Neaves WB, Walsh PC , Wilson JD. LH-hCG receptors and testosterone content during differentiation of the testis in the rabbit embryo. Endocrinology. 1975 Nov;97(5):1157-65.
  34. Walsh, P.C. and Siiteri, P.J.: Spironolactone induced suppression of plasma testosterone, androstenedione, and dehydroepiandrosterone in orchiectomized men with carcinoma of the prostate, In Normal and Abnormal Growth of the Prostate, ed. M. Goland. Charles C. Thomas Publishers, Springfield, Illinois, 1975, pp. 846-849.
  35. Walsh, P.C.: Intersex States, Chapter 2, In Urological Surgery, Second Edition, eds., Glenn, J.F. and Boyce, W.H., Harper and Row, 1975.
  36. Walsh PC . Benign prostatic hyperplasia:etiological considerations. Prog Clin Biol Res. 1976;6:1-8.
  37. Walsh PC , McLoughlin MG, Menon M, Tananis C. Measurement of androgen receptors in human prostatic tissue:methodological considerations. Prog Clin Biol Res. 1976;6:159- 68.
  38. Walsh PC , Curry N, Mills RC, Siiteri PK. Plasma androgen responce to hCG stimulation in prepubertal boys with hypospadias and cryptorchidism. J Clin Endocrinol Metab. 1976 Jan;42(1):52-9.
  39. Sloan WR, Walsh PC . Familial persistent Mullerian duct syndrome. J Urol. 1976 Apr;115(4):459-61.
  40. Walsh PC , Wilson JD. The induction of prostatic hypertrophy in the dog with androstanediol. J Clin Invest. 1976 Apr;57(4):1093-7.
  41. Clyde HR, Walsh PC , English RW. Elevated plasma testosterone and gonadotropin levels in infertile males with hyperthyroidism. Fertility & Sterility. 1976 Jun;27(6):662-6.
  42. Wilson, J.D., Walsh, P.C. and Siiteri, P.K.: Studies on the pathogenesis of BPH in the dog, In Benign Prostatic Hyperplasia, J.T. Grayhack, J.D. Wilson, and M.J. Scherbenski, (eds.) DHEW Publication No. (NIH) 76-1113, pp. 205-11, 1976.
  43. Walsh, P.C.: Experimental approaches to benign prostatic hypertrophy: Animal models utilizing the dog, rat, and mouse, In Benign Prostatic Hyperplasia, J.T. Grayhack, J.D. Wilson, and M.J. Scherbenske, (eds.) DHEW Publication No (NIH) 76-1113, pp. 215-22.
  44. Rajfer J, Walsh PC . The incidence of intersexuality in patients with hypospadias and cryptorchidism. J Urol. 1976 Dec;116(6):769-70.
  45. Walsh PC , Greco JM, Tananis CE, Hicks LL, McLoughlin MG, Menon M. The binding of a potent synthetic androgen--methyltrienolone (R 1881)--to cytosol preparations of human prostatic cancer. Trans Am Assoc Genitourin Surg. 1977;69:78-80.
  46. Rajfer J, Coffey DS, Walsh PC . Effects of hormones in the newborn period on the development of the penis. Surg Forum. 1977;28:570-3.
  47. Walsh PC . The endocrinology of testicular tumors. Recent Results Cancer Res. 1977;(60):196-201.
  48. Rajfer J, Walsh PC . Testicular descent. Birth Defects Orig Artic Ser. 1977;13(2):107-22. Review.
  49. Menon M, Tananis CE, McLoughlin MG, Lippman ME, Walsh PC . The measurement of androgen receptors in human prostatic tissue utilizing sucrose density centrifugation and a protamine precipitation assay. J Urol. 1977 Mar;117(3):309-12.
  50. Menon M, Tananis CE, McLoughlin MG, Walsh PC . Androgen receptors in human prostatic tissues:a review. Cancer Treat Rep. 1977 Mar-Apr;61(2):265-71. Review.
  51. Marshall FF, Walsh PC . Extrarenal manifestations of renal cell carcinoma. J Urol. 1977 Apr;117(4):439-40.
  52. Amrhein JA, Klingensmith GJ, Walsh PC , McKusick VA, Migeon CJ. Partial androgen insensitivity:the Reifenstein syndrome revisited. N Engl J Med. 1977 Aug 18;297(7):350- 6.
  53. Rajfer J, Walsh PC . Hormonal regulation of testicular descent:experimental and clinical observations. J Urol. 1977 Dec;118(6):985-90.
  54. Sanders RC, Duffy T, Mcloughlin MG, Walsh PC . Sonography in the diagnosis of retroperitoneal fibrosis. J Urol. 1977 Dec;118(6):944-6.
  55. Coffey, D.S., DeKlerk, D.P., and Walsh, P.C.: Benign prostatic hyperplasia: Current Concepts. Excerpta Medical International Congress Series No. 403, Endocrinologoy Proceedings of the V International Congress of Endocrinology, Hamburg, July 18-24, 976. Vol. 2:495-99, 1977.
  56. Walsh, P.C. and Amelar, R.D.: Embryology, anatomy, and physiology of the male reproductive system. In Male Infertility, eds. R.D. Amelar, L. Dubin, P.C. Walsh, W.B. Saunders, Philadelphia, 1977, pp. 3-32.
  57. Walsh, P.C.: Endocrine and chromosomal factors associated with infertility. Ibid. pp. 33- 56.
  58. Walsh, P.C.: Endocrine evaluation of the infertile male. Ibid. pp. 153-58.
  59. Walsh, P.C. and Amelar, R.D.: Medical management of male infertility. Ibid. pp. 179- 90.
  60. Menon M, Tananis CE, Hicks LL, Hawkins EF, McLoughlin MG, Walsh PC . Characterization of the binding of a potent synthetic androgen, methyltrienolone, to human tissues. J Clin Invest. 1978 Jan;61(1):150-62.
  61. Rajfer J, Walsh PC . Testicular descent. Normal and abnormal. Urol Clin North Am. 1978 Feb;5(1):223-35. Review.
  62. Walsh PC . The differential diagnosis of ambiguous genitalia in the newborn. Urol Clin North Am. 1978 Feb;5(1):213-21.
  63. Rajfer J, Eggleston JC, Sanders RC, Walsh PC . Fever and prostatic mass in a young man. J Urol. 1978 Apr;119(4):555-8.
  64. Rajfer J, Mendelsohn G, Arnheim J, Jeffs RD, Walsh PC . Dysgenetic male pseudohermaphroditism. J Urol. 1978 Apr;119(4):525-7.
  65. Walsh PC , Migeon CJ. The phenotypic expression of selective disorders of male sexual differentiation. J Urol. 1978 May;119(5):627-9.
  66. Walsh PC , Wilson JD, Allen TD, Madden JD, Porter JC, Neaves WB, Griffin JE, Goodwin WE. Clinical and endocrinological evaluation of patients with congenital microphallus. J Urol. 1978 Jul;120(1):90-5.
  67. Michigan S, Whelton PK, Walsh PC . Forgotten kidney:asynchronous bilateral ureteropelvic junction obstruction. Urology. 1978 Nov;12(5):565-6.
  68. McPhee SJ, Katz RD, Olson JL, Walsh PC . Clinical conferences at the Johns Hopkins Hospital. Prostatic carcinoma. Johns Hopkins Med J. 1978 Dec;143(6):207-11.
  69. Walsh PC , Hicks LL. Characterization and measurement of androgen receptors in human prostatic tissue. Prog Clin Biol Res. 1979;33:51-63.
  70. Heston WD, Menon M, Tananis C, Walsh PC . Androgen, estrogen and progesterone receptors of the R3327H Copenhagen rat prostatic tumor. Cancer Lett. 1979 Jan;6(1):45- 50.
  71. Walsh PC . A new cause of male infertility. N Engl J Med. 1979 Feb 1;300(5):253-4.
  72. Reiner WG, Walsh PC . An anatomical approach to the surgical management of the dorsal vein and Santorini's plexus during radical retropubic surgery. J Urol. 1979 Feb;121(2):198-200.
  73. Hicks LL, Walsh PC . A microassay for the measurement of androgen receptors in human prostatic tissue. Steroids. 1979 Apr;33(4):389-406.
  74. Davies TF, Walsh PC , Hodgen GD, Dufau ML, Catt KJ. Characterization of the primate luteinizing hormone receptor in testis homogenates and Leydig cells. J Clin Endocrinol Metab. 1979 Apr;48(4):680-5.
  75. Lepor H, Walsh PC . Idiopathic retroperitoneal fibrosis. J Urol. 1979 Jul;122(1):1-6. Review.
  76. Reiner WG, Scott WW, Eggleston JC, Walsh PC . Long-term survival after hormonal therapy for stage D prostatic cancer. J Urol. 1979 Aug;122(2):183-4.
  77. DeKlerk DP, Coffey DS, Ewing LL, McDermott IR, Reiner WG, Robinson CH, Scott WW, Strandberg JD, Talalay P, Walsh PC , Wheaton LG, Zirkin BR. Comparison of spontaneous and experimentally induced canine prostatic hyperplasia. J Clin Invest. 1979 Sep;64(3):842-9.
  78. Walsh PC , Hensle T, Wigger HJ. Ambiguous genitalia in a child. Urology. 1979 Oct;14(4):405-10.
  79. Whelton PK, Harris AP, Russell RP, Walsh PC , Williams GM, Harrington DP, Walker WG. Renovascular hypertension:comparison of medical and surgical therapy. Clin Sci (Lond). 1979 Dec;57 Suppl 5:445s-447s.
  80. Walsh, P.C. and Scott, W.W.: Intersex. In Pediatric Surgery, (eds) M.M. Ravitch, K.J., Welch, C.D., Benson, E. Aberdeen, J.G. Randolph. Chicago Year Book Medical Publishers, Inc., 1979, pp. 1411-25.
  81. Walsh, P.C.: Benign prostatic hyperplasia. In Campbell's Urology, (eds) J.H. Harrison, R.F. Gittes, T.A. Stamey, A.D. Perlmutter, P.C. Walsh. Philadelphia, W.B. Saunders, 1979, pp. 949-64
  82. Wilson, J.D. and Walsh, P.C.: disorders of sexual differentiation. Ibid. Pp. 1484-1532.
  83. Menon, M. And Walsh, P.C.: Hormonal therapy for prostatic cancer. In Prostatic Cancer (eds) G.P. Murphy. PSG Publishing Company, Inc. Littleton, MA 1979, pp. 175-200.
  84. Zwartendijk, J. and Walsh, P.C.: Radical retropubic prostatectomy. In Current and Future Trends in Urology, edited by S.I. Miranda and H.J. de Voogt, Bunge Scientific Publishers, pp. 102-110, 1979.
  85. Zerhouni EA, Siegelman SS, Walsh PC , White RI. Elevated pressure in the left renal vein in patients with varicocele:preliminary observations. J Urol. 1980 Apr;123(4):512-3.
  86. Walsh PC , Jewett HJ. Radical surgery for prostatic cancer. Cancer. 1980 Apr 15;45(7 Suppl):1906-11.
  87. Scott WW, Menon M, Walsh PC . Hormonal therapy of prostatic cancer. Cancer. 1980 Apr 15;45(7 Suppl):1929-36.
  88. Rosenshein NB, Lichter AS, Walsh PC . Cervical cancer complicated by a pelvic kidney. J Urol. 1980 May;123(5):766-7.
  89. Trachtenberg J, Hicks LL, Walsh PC . Androgen and estrogen-receptor content in spontaneous and experimentally induced canine prostatic hyperplasia. J Clin Invest. 1980 May;65(5):1051-9.
  90. Walsh, P.C. and Wilson, J.D.: disturbances of sexual function and reproduction in men. In Harrison's Principles of Internal Medicine, (eds) K.J. Isselbacher, R.D. Adams, E. Braunwald, R.B. Petersdorf, and J.D. Wilson. McGraw-Hill, New York, 1980, pp. 229- 232.
  91. Murphy JB, Emmott RC, Hicks LL, Walsh PC . Estrogen receptors in the human prostate, seminal vesicle, epididymis, testis, and genital skin:a marker for estrogen-responsive tissues? J Clin Endocrinol Metab. 1980 May;50(5):938-48.
  92. Walsh PC . Radical prostatectomy for the treatment of localized prostatic carcinoma. Urol Clin North Am. 1980 Oct;7(3):583-91.
  93. Howards SS, Walsh PC . Radioimmunoassay for prostatic acid phosphatase. J Urol. 1980 Nov;124(5):753-4.
  94. Schmeller NT, Siegelman SS, Walsh PC . Anatomical considerations in suprahilar lymph node dissection for testicular tumors. Urol Int. 1981;36(6):341-5.
  95. Hawkins, E.F., Trachtenberg, J., Hicks, L.L., and Walsh, P.C.: Androgen and estrogen receptors in the canine prostate. J. of Androl. 1980; l(1), #5:234-43.
  96. Trachtenberg J, Hicks LL, Walsh PC . Methods for the determination of androgen receptor content in human prostatic tissue. Invest Urol. 1981 Mar;18(5):349-54.
  97. Walsh, P.C., Tyson, J.E.A., Hsu, T.H.: The gonads. In The Principles and Practice of Medicine, Twentieth Edition, (eds) A.M. Harvey, R.J. Johns, V.A. McKusick, A.H. Owens, Jr., R.S. Ross, Appleton-Century Croft, New York, 1980, pp. 893-918.
  98. Cantrell BB, DeKlerk DP, Eggleston JC, Boitnott JK, Walsh PC . Pathological factors that influence prognosis in stage A prostatic cancer:the influence of extent versus grade. J Urol. 1981 Apr;125(4):516-20.
  99. White RI Jr, Kaufman SL, Barth KH, Kadir S, Smyth JW, Walsh PC . Occlusion of varicoceles wih detachable balloons. Radiology. 1981 May;139(2):327-34.
  100. Fichman KR, Nyberg LM, Bujnovszky P, Brown TR, Walsh PC . The ontogeny of the androgen receptor in human foreskin. J Clin Endocrinol Metab. 1981 May;52(5):919-23.
  101. Walsh PC . Randomized study of prostatic cancer. Urology. 1981 Aug;18(2):219-20.
  102. Ehrlichman RJ, Kaufman SL, Siegelman SS, Trump DL, Walsh PC . Computerized tomography and lymphangiography in staging testis tumors. J Urol. 1981 Aug;126(2):179-81.
  103. Feinstein RS, Gatewood OM, Goldman SM, Copeland B, Walsh PC , Siegelman SS. Computerized tomography in the diagnosis of retroperitoneal fibrosis. J Urol. 1981 Aug;126(2):255-9.
  104. Walsh PC , White RI Jr. Balloon occlusion of the internal spermatic vein for the treatment of varicoceles. JAMA. 1981 Oct 9;246(15):1701-2.
  105. Whelton PK, Harris AP, Russell RP, Walsh PC , Williams GM, Harrington DP, Walker WG. Renovascular hypertension:results of medical and surgical therapy. Johns Hopkins Med J. 1981 Dec;149(6):213-9.
  106. . Elder JS, Isaacs JT, Walsh PC . Androgenic sensitivity of the gubernaculum testis:evidence for hormonal/mechanical interactions in testicular descent. J Urol. 1982 Jan;127(1):170-6.
  107. Trachtenberg J, Bujnovszky P, Walsh PC . Androgen receptor content of normal and hyperplastic human prostate. J Clin Endocrinol Metab. 1982 Jan;54(1):17-21.
  108. Trachtenberg J, Walsh PC . Correlation of prostatic nuclear androgen receptor content with duration of response and survival following hormonal therapy in advanced prostatic cancer. J Urol. 1982 Mar;127(3):466-71.
  109. Elder JS, Jewett HJ, Walsh PC . Radical perineal prostatectomy for clinical stage B2 carcinoma of the prostate. J Urol. 1982 Apr;127(4):704-6.
  110. Goldman SM, Gatewood OM, Walsh PC , Dornhorst A, Siegelman SS. CT configuration of the enlarged adrenal gland. J Comput Assist Tomogr. 1982 Apr;6(2):276-80.
  111. Bias WB, Nyberg LM Jr, Hochberg MC, Walsh PC . Peyronie's disease:a newly recognized autosomal-dominant trait. Am J Med Genet. 1982 Jun;12(2):227-35.
  112. Nyberg LM Jr, Bias WB, Hochberg MC, Walsh PC . Identification of an inherited form of Peyronie's disease with autosomal dominant inheritance and association with Dupuytren's contracture and histocompatibility B7 cross-reacting antigens. J Urol. 1982 Jul;128(1):48-51.
  113. Lepor H, Ross A, Walsh PC . The influence of hormonal therapy on survival of men with advanced prostatic cancer. J Urol. 1982 Aug;128(2):335-40.
  114. Walsh PC , Donker PJ. Impotence following radical prostatectomy:insight into etiology and prevention. J Urol. 1982 Sep;128(3):492-7.
  115. Ekman P, Barrack ER, Walsh PC . Simultaneous measurement of progesterone and androgen receptors in human prostate:a microassay. J Clin Endocrinol Metab. 1982 Dec;55(6):1089-99.
  116. Walsh PC , Lepor H, Eggleston JC. Radical prostatectomy with preservation of sexual function:anatomical and pathological considerations. Prostate. 1983;4(5):473-85.
  117. Isaacs JT, Brendler CB, Walsh PC . Changes in the metabolism of dihydrotestosterone in the hyperplastic human prostate. J Clin Endocrinol Metab. 1983 Jan;56(1):139-46.
  118. Walsh, P.C. and Wilson, Jean D.: Disturbances of sexual and reproductive function in men. In Harrison's Principles of Internal Medicine, 10th Edition, (eds) Petersdorf, Adams, Braunwald, Isselbiacher, Martin, and Wilson, McGraw-Hill, New York, 1983, pp. 240-43.
  119. Barrack ER, Bujnovszky P, Walsh PC . Subcellular distribution of androgen receptors in human normal, benign hyperplastic, and malignant prostatic tissues:characterization of nuclear salt-resistant receptors. Cancer Res. 1983 Mar;43(3):1107-16.
  120. Kaufman SL, Kadir S, Barth KH, Smyth JW, Walsh PC , White RI Jr. Mechanisms of recurrent varicocele after balloon occlusion or surgical ligation of the internal spermatic vein. Radiology. 1983 May;147(2):435-40.
  121. Brendler CB, Berry SJ, Ewing LL, McCullough AR, Cochran RC, Strandberg JD, Zirkin BR, Coffey DS, Wheaton LG, Hiler ML, Bordy MJ, Niswender GD, Scott WW, Walsh PC. Spontaneous benign prostatic hyperplasia in the beagle. Age-associated changes in serum hormone levels, and the morphology and secretory function of the canine prostate. J Clin Invest. 1983 May;71(5):1114-23.
  122. Ekman P, Barrack ER, Greene GL, Jensen EV, Walsh PC . Estrogen receptors in human prostate:evidence for multiple binding sites. J Clin Endocrinol Metab. 1983 Jul;57(1):166-76.
  123. Droller MJ, Walsh PC . Therapeutic efficacy of salvage cystectomy. Do results reflect natural history of bladder cancer? Urology. 1983 Aug;22(2):118-22.
  124. Walsh PC , Hutchins GM, Ewing LL. Tissue content of dihydrotestosterone in human prostatic hyperplasis is not supranormal. J Clin Invest. 1983 Nov;72(5):1772-7.
  125. Walsh PC . Human benign prostatic hyperplasia:etiological considerations. Prog Clin Biol Res. 1984;145:1-25. Review.
  126. Brendler CB, Isaacs JT, Follansbee AL, Walsh PC . The use of multiple variables to predict response to endocrine therapy in carcinoma of the prostate:a preliminary report. J Urol. 1984 Apr;131(4):694-700.
  127. Marshall FF, Walsh PC . In situ management of renal tumors:renal cell carcinoma and transitional cell carcinoma. J Urol. 1984 Jun;131(6):1045-9.
  128. Berry SJ, Coffey DS, Walsh PC , Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol. 1984 Sep;132(3):474-9.
  129. Walsh PC , Mostwin JL. Radical prostatectomy and cystoprostatectomy with preservation of potency. Results using a new nerve-sparing technique. Br J Urol. 1984 Dec;56(6):694- 7.
  130. Lepor H, Gregerman M, Crosby R, Mostofi FK, Walsh PC . Precise localization of the autonomic nerves from the pelvic plexus to the corpora cavernosa:a detailed anatomical study of the adult male pelvis. J Urol. 1985 Feb;133(2):207-12.
  131. Walsh, P.C.: Diseases of the prostate. In Cecil's Textbook of Medicine, 17th Edition (eds) Wyngaarden and Smith, W B. Saunders, Philadelphia, PA, 1985, pp. 1375-79.
  132. Peters CA, Walsh PC . Blood transfusion and anesthetic practices in radical retropubic prostatectomy. J Urol. 1985 Jul;134(1):81-3.
  133. Eggleston JC, Walsh PC . Radical prostatectomy with preservation of sexual function:pathological findings in the first 100 cases. J Urol. 1985 Dec;134(6):1146-8.
  134. Droller MJ, Walsh PC . Intensive intravesical chemotherapy in the treatment of flat carcinoma in situ:is it safe? J Urol. 1985 Dec;134(6):1115-7.
  135. Dahnert WF, Hamper UM, Eggleston JC, Walsh PC , Sanders RC. Prostatic evaluation by transrectal sonography with histopathologic correlation:the echopenic appearance of early carcinoma. Radiology. 1986 Jan;158(1):97-102.
  136. Walsh, P.C.: Benign Prostatic Hyperplasia. In Campbell's Textbook of Urology, 5th Edition, (eds) Walsh, P.C., Gittes, R.F., Perlmutter, A.D., and Stamey, T.A., WlB. Saunders, Philadelphia, 1986, Vol. 2, pp. 1248-1265.
  137. Walsh, P.C.: Radical retropubic prostatectomy. InCampbell's Textbook of Urology, 5th Edition, (eds) Walsh, P.C., Gittes, R.F., Perlmutter, A.D., and Stamey, T.A., W.B. Walsh PC. Saunders, Philadelphia, 1986, vol. 3, pp. 2754-2775.
  138. Walsh, P.C.: Radical prostatectomy and cystoprostatectomy with preservation of potency using a nerve-sparing technique. In Current Urologic Therapy, 2nd Edition (ed) J.J. Kaufman. W.B. Saunders, Philadelphia, 1986, pp. 331-333.
  139. Walsh, P.C.: Radical prostatectomy with preservation of sexual function: Evolution of a surgical procedure. AUA UPDATE SERIES, Lesson 5, Vol. V:1-8, 1986.
  140. Walsh, P.C.: Radical retropubic prostatectomy– An anatomic approach with preservation of sexual function. A pictorial review of urologic procedures. Presented by Bristol Laboratories, LTI Medica, New Scotland, NY 1986.
  141. Walsh, P.C.: Fine needle aspiration of the prostate--why has it taken so long to accept? J Urol. 1986 Feb;135(2):334-5.
  142. Dahnert WF, Hamper UM, Walsh PC , Eggleston JC, Sanders RC. The echogenic focus in prostatic sonograms, with xeroradiographic and histopathologic correlation. Radiology. 1986 Apr;159(1):95-100.
  143. Benson MC, Walsh PC . The application of flow cytometry to the assessment of tumor cell heterogeneity and the grading of human prostatic cancer:preliminary results. J Urol. 1986 Jun;135(6):1194-8.
  144. Jarow JP, Berkovitz GD, Migeon CJ, Gearhart JP, Walsh PC . Elevation of serum gonadotropins establishes the diagnosis of anorchism in prepubertal boys with bilateral cryptorchidism. J Urol. 1986 Jul;136(1 Pt 2):277-9.
  145. Epstein JI, Paull G, Eggleston JC, Walsh PC . Prognosis of untreated stage A1 prostatic carcinoma:a study of 94 cases with extended followup. J Urol. 1986 Oct;136(4):837-9.
  146. Hamper UM, Dahnert WF, Eggleston JC, Walsh PC , Sanders RC. Ultrasonography of prostatic carcinoma employing amplitude-enveloped (AM) and frequency-demodulated (FM) imaging:in vivo, in vitro, and pathologic correlation. J Ultrasound Med. 1986 Oct;5(10):557-62.
  147. Walsh, P.C. and Wilson, Jean D.: Impotence and infertility in men. In Harrison's Principles of Internal Medicine, 11th Edition, (eds) Braunwald, Isselbacher, Petersdorf, Wilson, Martin and Fauci, McGraw-Hill, New York, 1986, pp. 217-20.
  148. Makofski, R.A., Massey, J.T., Mark, F.F., Weiskopf, Jr., F.B., Guier, W.H., Walsh, P.C. and Marshall, F.F.: Means and method for the non-invasive fragmentation of body concretions. United States Patent #4,610,249 dated September 9, 1986.
  149. Oesterling JE, Epstein JI, Walsh PC . The inability of adrenal androgens to stimulate the adult human prostate:an autopsy evaluation of men with hypogonadotropic hypogonadism and panhypopituitarism. J Urol. 1986 Nov;136(5):1030-4.
  150. Epstein, J.I. and Walsh, P.C.: Stage A prostate cancer is incidental but not insignificant. In Problems in Urology, Vol. 1, No. 1, (ed) Paulson, D., J.B. Lippincott Co., January/March 1987, Philadelphia, pp. 34-41.
  151. Walsh, P.C. and Epstein, J.I.: Radical prostatectomy with preservation of sexual function: Impact on cancer control. In Problems of Urology, Vol. 1, No. 1, (ed) Paulson, D., J. B. Lippincott Co., January/March 1987, Philadelphia, pp. 42-52.
  152. Epstein JI, Oesterling JE, Eggleston JC, Walsh PC . Frozen section detection of lymph node metastases in prostatic carcinoma:accuracy in grossly uninvolved pelvic lymphadenectomy specimens. J Urol. 1986 Dec;136(6):1234-7.
  153. Lepor H. and Walsh PC . The role of radical prostatectomy in the management of stage B adenocarcinoma of the prostate. Prog Clin Biol Res. 1987;243B:343-56. Review.
  154. Lepor, H. and Walsh, P.C.: Stage B1 prostatic adenocarcinoma. In Current Therapy in Genitourinary Surgery, (eds) Resnick and Kursh. B.C. Decker, Inc. Toronto- Philadelphia, pp. 92-95, 1987.
  155. Barrack ER, Brendler CB, Walsh PC . Steroid receptor and biochemical profiles in prostatic cancer: Correlation with response to hormonal treatment. In: Prog Clin Biol Res. 243A Prostate Cancer Part A: Research, Endocrine Treatment and Histopathology, (eds) G.P. Murphy, S. Khoury, R. Kuss, C. Chatelain and L. Denis, Alan R. Liss, Inc., New York, pp. 79-97 (1987).
  156. Oesterling JE, Epstein JI, Walsh PC . Long-term autopsy findings following radical prostatectomy. Urology. 1987 Jun;29(6):584-8.
  157. Schlegel PN, Walsh PC . Simultaneous preperitoneal hernia repair during radical pelvic surgery. J Urol. 1987 Jun;137(6):1180-3.
  158. Oesterling JE, Brendler CB, Epstein JI, Kimball AW Jr, Walsh PC . Correlation of clinical stage, serum prostatic acid phosphatase and preoperative Gleason grade with final pathological stage in 275 patients with clinically localized adenocarcinoma of the prostate. J Urol. 1987 Jul;138(1):92-8.
  159. Walsh PC , Lepor H. The role of radical prostatectomy in the management of prostatic cancer. Cancer. 1987 Aug 1;60(3 Suppl):526-37.
  160. Peters CA, Walsh PC . The effect of nafarelin acetate, a luteinizing-hormone-releasing hormone agonist, on benign prostatic hyperplasia. N Engl J Med. 1987 Sep 3;317(10):599-604.
  161. Walsh PC , Epstein JI, Lowe FC. Potency following radical prostatectomy with wide unilateral excision of the neurovascular bundle. J Urol. 1987 Oct;138(4):823-7.
  162. Chan DW, Bruzek DJ, Oesterling JE, Rock RC, Walsh PC . Prostate-specific antigen as a marker for prostatic cancer:a monoclonal and a polyclonal immunoassay compared. Clin Chem. 1987 Oct;33(10):1916-20.
  163. Walsh PC . Radical prostatectomy, preservation of sexual function, cancer control. The controversy. Urol Clin North Am. 1987 Nov;14(4):663-73. Review.
  164. Schlegel PN, Walsh PC . Neuroanatomical approach to radical cystoprostatectomy with preservation of sexual function. J Urol. 1987 Dec;138(6):1402-6.
  165. Walsh PC . Adjuvant radiotherapy after radical prostatectomy:is it indicated? J Urol. 1987 Dec;138(6):1427-8.
  166. Walsh, P.C.: Diseases of the Prostate. In Cecil Textbook of Medicine, 18th Edition. (Eds) Wyngaarden and Smith, W.B. Saunders, Philadelphia, PA 1988, pp. 1421-1425.
  167. Rock, R.C., Chan, D.W., Bruzek, D., Waldron, C., Oesterline, J.E., and Walsh, P.C.: Evaluation of a monoclonal immunoradiometric assay for prostate-specific antigen. Clin. Chem. 33:2257-2261, 1987.
  168. Walsh, P.C.: Technique of radical retropubic prostatectomy with preservation of sexual function–An anatomic approach. In Diagnosis and Management of Genitourinary Cancer, (eds) Skinnerand Lieskovsky, W.B. Saunders, Philadelphia, 1988, pp. 753-78.
  169. Walsh, P.C.: Radical retropubic prostatectomy: An anatomical approach with preservation of sexual function. In Current Operative Surgery, (ed) Mundy, Bailliere, Tindall, London, 1988, pp. 35-55.
  170. Walsh PC . Radical retropubic prostatectomy with reduced morbidity:an anatomic approach. NCI Monogr. 1988;(7):133-7.
  171. Lepor H, Walsh PC . Long-term results of radical prostatectomy in clinically localized prostate cancer:experience at the Johns Hopkins Hospital. NCI Monogr. 1988;(7):117-22.
  172. Walsh PC . Preservation of sexual function in the surgical treatment of prostatic cancer-- an anatomic surgical approach. Important Adv Oncol. 1988;:161-70. Review.
  173. Walsh PC . The role of estrogen/androgen synergism in the pathogenesis of benign prostatic hyperplasia. J Urol. 1988 Apr;139(4):826.
  174. Oesterling JE, Chan DW, Epstein JI, Kimball AW Jr, Bruzek DJ, Rock RC, Brendler CB, Walsh PC . Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy. J Urol. 1988 Apr;139(4):766-72.
  175. Epstein JI, Oesterling JE, Walsh PC . The volume and anatomical location of residual tumor in radical prostatectomy specimens removed for stage A1 prostate cancer. J Urol. 1988 May;139(5):975-9.
  176. Epstein JI, Oesterling JE, Walsh PC . Tumor volume versus percentage of specimen involved by tumor correlated with progression in stage A prostatic cancer. J Urol. 1988 May;139(5):980-4.
  177. . Walsh PC . Nerve sparing radical prostatectomy for early stage prostate cancer. Semin Oncol. 1988 Aug;15(4):351-8.
  178. Marshall FF, Weiskopf F, Singh A, Mark F, Leo F, Sanders R, Makofski R, Walsh PC , Smith N. A prototype device for nonimmersion shock wave lithotripsy using ultrasonography for calculus localization. J Urol. 1988 Aug;140(2):249-53.
  179. Epstein, J.I. and Walsh, P.C.: The classification and prognosis of untreated stage A1 and A2 prostate cancer with a comparison of their histologic findings at radical prostatectomy. In A Multidisciplinary Analysis of Controversies in the Management of Prostate Cancer, (eds) D.S. Coffey, M.I. Resnick, F.A. Dorr, J.P. Karr; Plenum Press, New York, 1988, pp. 295-97.
  180. Walsh, P.C., Oesterling, J.E., and Lepor, H.: Radical prostatectomy for the treatment of localized prostatic cancer. In A Multidisciplinary Analysis of Controversies in the Management of Prostate Cancer, (eds) D.S. Coffey, M.I. Resnick, F.A. Dorr, J.P. Karr; Plenum Press, New York, 1988, pp. 123-40.
  181. Whitmore, Jr., W.F., Catalona, W.J., Grayhack, J.T., Hanks, G., Peters, P.C., Shipley, W.U., and Walsh, P.C.: Organ systems program staging classification for prostate cancer. In A Multidisciplinary Analysis of Controversies in the Management of Prostate Cancer. (Eds) D.S. Coffey, M.I. Resnick, F.A. Dorr, J.P. Karr; Plenum Press, New York, 1988, pp. 295-97.
  182. Walsh PC , Schlegel PN. Radical pelvic surgery with preservation of sexual function. Ann Surg. 1988 Oct;208(4):391-400.
  183. Walsh PC , Oesterling JE, Epstein JI, Bruzek DJ, Rock RC, Chan DW. The value of prostate-specific antigen in the management of localized prostatic cancer. Prog Clin Biol Res. 1989;303:27-33.
  184. Lepor H, Kimball AW, Walsh PC . Cause-specific actuarial survival analysis:a useful method for reporting survival data in men with clinically localized carcinoma of the prostate. J Urol. 1989 Jan;141(1):82-4.
  185. Partin AW, Epstein JI, Cho KR, Gittelsohn AM, Walsh PC . Morphometric measurement of tumor volume and per cent of gland involvement as predictors of pathological stage in clinical stage B prostate cancer. J Urol. 1989 Feb;141(2):341-5.
  186. Quinlan DM, Nelson RJ, Partin AW, Mostwin JL, Walsh PC . The rat as a model for the study of penile erection. J Urol. 1989 Mar;141(3):656-61.
  187. Weber JP, Oesterling JE, Peters CA, Partin AW, Chan DW, Walsh PC . The influence of reversible androgen deprivation on serum prostate-specific antigen levels in men with benign prostatic hyperplasia. J Urol. 1989 Apr;141(4):987-92.
  188. Alexander RB, Maguire MG, Epstein JI, Walsh PC . Pathological stage is higher in older men with clinical stage B1 adenocarcinoma of the prostate. J Urol. 1989 Apr;141(4):880- 2.
  189. Walsh, P.C.: Radical retropubic prostatectomy with preservation of sexual function: An update after 500 cases. Distributed by Norwich Eaton Pharmaceuticals, Inc. Norwich, New York.
  190. Walsh, P.C.: EDITORIAL - One journal with everything. J. Urol. 141:194, 1989.
  191. Mohler JL, Erozan YS, Walsh PC , Epstein JI. Fine-needle core and aspiration biopsy. A new method for diagnosis of prostatic carcinoma. Cancer. 1989 May 1;63(9):1846-55.
  192. Walsh, P.C.: Radical prostatectomy with preservation of sexual function following wide unilateral excision of the neurovascular bundle. In Difficult Problems in Urologic Surgery, (ed) W. Scott McDougal, Year Book Medical Publishers, Chicago, 1988, pp. 185-93.
  193. Schlegel PN, Walsh PC . The use of the preperitoneal approach for the simultaneous repair of inguinal hernia during surgery on the bladder and prostate. World J Surg. 1989 Sep-Oct;13(5):555-9.
  194. Carter HB, Hamper UM, Sheth S, Sanders RC, Epstein JI, Walsh PC . Evaluation of transrectal ultrasound in the early detection of prostate cancer. J Urol. 1989 Oct;142(4):1008-10.
  195. Carter, H.B., Partin, A.W., Oesterling, J.E., Weber, J.P., Epstein, J.I., Chan, D.W., Rock, R.C., and Walsh, P.C.: The use of prostate-specific antigen in the management of patients with prostate cancer: The Johns Hopkins Experience. In Clinical Aspects of Prostate Cancer, (eds) W.J. Catalona, D.S. Coffey, J.P. Karr, Elsevier Science Publishing Company, Inc., New York, 1989, pp. 247-51.
  196. Steinberg GD, Carter BS, Beaty TH, Childs B, Walsh PC . Family history and the risk of prostate cancer. Prostate. 1990;17(4):337-47.
  197. Walsh PC . Radical prostatectomy in locally confined prostatic carcinoma. Prog Clin Biol Res. 1990;359:199-207; discussion 223-9. Review.
  198. Walsh PC . Prostate carcinoma-current status and future direction. Nippon Hinyokika Gakkai Zasshi. 1990;81(13 Suppl):1978-9.
  199. Schlegel, P.N. and Walsh, P.C.: Impotence following radical prostatectomy. In COMMON PROBLEMS IN INFERTILITY AND IMPOTENCE (ed) Jacob Rajfer, Yearbook Medical Publishers, Chicago, 1990, pp. 356-361.
  200. Christensen WN, Partin AW, Walsh PC , Epstein JI. Pathologic findings in clinical stage A2 prostate cancer. Relation of tumor volume, grade, and location to pathologic stage. Cancer. 1990 Feb 15;65(4):1021-7. Review.
  201. Walsh PC , Brendler CB, Chang T, Marshall FF, Mostwin JI, Stutzman R, Schlegel PN. Preservation of sexual function in men during radical pelvic surgery. Md Med J. 1990 Apr;39(4):389-93.
  202. Partin AW, Carter HB, Chan DW, Epstein JI, Oesterling JE, Rock RC, Weber JP, Walsh PC. Prostate specific antigen in the staging of localized prostate cancer:influence of tumor differentiation, tumor volume and benign hyperplasia. J Urol. 1990 Apr;143(4):747-52.
  203. Walsh PC , Oesterling JE. Improved hemostasis during simple retropubic prostatectomy. J Urol. 1990 Jun;143(6):1203-4.
  204. Hamper UM, Epstein JI, Sheth S, Walsh PC , Sanders RC. Cystic lesions of the prostate gland. A sonographic--pathologic correlation. J Ultrasound Med. 1990 Jul;9(7):395-402.
  205. Coffey DS, Walsh PC . Clinical and experimental studies of benign prostatic hyperplasia. Urol Clin North Am. 1990 Aug;17(3):461-75. Review.
  206. Walsh PC , Quinlan DM, Morton RA, Steiner MS. Radical retropubic prostatectomy. Improved anastomosis and urinary continence. Urol Clin North Am. 1990 Aug;17(3):679-84.
  207. Hamper UM, Sheth S, Walsh PC , Epstein JI. Bright echogenic foci in early prostatic carcinoma:sonographic and pathologic correlation. Radiology. 1990 Aug;176(2):339-43.
  208. Gearhart JP, Donohoue PA, Brown TR, Walsh PC , Berkovitz GD. Endocrine evaluation of adults with mild hypospadias. J Urol. 1990 Aug;144(2 Pt 1):274-7.
  209. Brendler CB, Schlegel PN, Walsh PC . Urethrectomy with preservation of potency. J Urol. 1990 Aug;144(2 Pt 1):270-3.
  210. Rifkin MD, Zerhouni EA, Gatsonis CA, Quint LE, Paushter DM, Epstein JI, Hamper U, Walsh PC , McNeil BJ. Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer. Results of a multi-institutional cooperative trial. N Engl J Med. 1990 Sep 6;323(10):621-6.
  211. Carter HB, Partin AW, Epstein JI, Chan DW, Walsh PC . The relationship of prostate specific antigen levels and residual tumor volume in stage A prostate cancer. J Urol. 1990 Nov;144(5):1167-70; discussion 1170-1.
  212. Brendler CB, Steinberg GD, Marshall FF, Mostwin JL, Walsh PC . Local recurrence and survival following nerve-sparing radical cystoprostatectomy. J Urol. 1990 Nov;144(5):1137-40; discussion 1140-1.
  213. Hamper UM, Sheth S, Walsh PC , Holtz PM, Epstein JI. Carcinoma of the prostate:value of transrectal sonography in detecting extension into the neurovascular bundle. AJR Am J Roentgenol. 1990 Nov;155(5):1015-9.
  214. Steinberg GD, Epstein JI, Piantadosi S, Walsh PC . Management of stage D1 adenocarcinoma of the prostate:the Johns Hopkins experience 1974 to 1987. J Urol. 1990 Dec;144(6):1425-32.
  215. Walsh, P.C.: Prostate Cancer Update, Winter 1991 - Published by The James Buchanan Brady Urological Institute, The Johns Hopkins Hospital, Baltimore, Maryland 21205.
  216. Schlegel, P.N. and Walsh, P.C.: Preperitoneal hernia repair during urological surgery. In OPERATIVE UROLOGY, (ed) Fray F. Marshall, W.B. Saunders Company, Philadelphia, 1991, pp. 114-18.
  217. Walsh, P.C. and Schlegel, P.N.: Radical cystectomy. In OPERATIVE UROLOGY, (ed) Fray F. Marshall, W.B. Saunders Company, Philadelphia, 1991, pp. 129-42.176. 217a. Walsh, P.C.: Retropubic prostatectomy for benign and malignant diseases. In OPERATIVE UROLOGY, (ed) Fray F. Marshall, W.B. Saunders Company, Philadelphia, 1991, pp.264-289.
  218. Brendler, C.B. and Walsh, P.C.: Urethrectomy with preservation of potency. In OPERATIVE UROLOGY, (ED) Fray F. Marshall, W.B. Saunders Company, Philadelphia, 1991, pp. 264-289.
  219. Carter BS, Steinberg GD, Beaty TH, Childs B, Walsh PC . Familial risk factors for prostate cancer. Cancer Surv. 1991;11:5-13. Review.
  220. Carter HB, Brem RF, Tempany CM, Yang A, Epstein JI, Walsh PC , Zerhouni EA. Nonpalpable prostate cancer:detection with MR imaging. Radiology. 1991 Feb;178(2):523-5.
  221. Quinlan DM, Nelson RJ, Walsh PC . Cavernous nerve grafts restore erectile function in denervated rats. J Urol. 1991 Feb;145(2):380-3.
  222. Partin AW, Oesterling JE, Epstein JI, Horton R, Walsh PC . Influence of age and endocrine factors on the volume of benign prostatic hyperplasia. J Urol. 1991 Feb;145(2):405-9.
  223. Hamper UM, Sheth S, Walsh PC , Holtz PM, Epstein JI. Capsular transgression of prostatic carcinoma:evaluation with transrectal US with pathologic correlation. Radiology. 1991 Mar;178(3):791-5.
  224. Marshall FF, Mostwin JL, Radebaugh LC, Walsh PC , Brendler CB. Ileocolic neobladder post-cystectomy:continence and potency. J Urol. 1991 Mar;145(3):502-4.
  225. Steiner MS, Morton RA, Walsh PC . Impact of anatomical radical prostatectomy on urinary continence. J Urol. 1991 Mar;145(3):512-4; discussion 514-5.
  226. Weber JP, Walsh PC , Peters CA, Spivak JL. Effect of reversible androgen deprivation on hemoglobin and serum immunoreactive erythropoietin in men. Am J Hematol. 1991 Mar;36(3):190-4.
  227. Sheth S, Hamper UM, Walsh PC , Holtz PM, Epstein JI. Stage A adenocarcinoma of the prostate:transrectal US and sonographic-pathologic correlation. Radiology. 1991 Apr;179(1):35-9.
  228. Christensen WN, Steinberg G, Walsh PC , Epstein JI. Prostatic duct adenocarcinoma. Findings at radical prostatectomy. Cancer. 1991 Apr 15;67(8):2118-24.
  229. Vaughan ED Jr, Walsh PC . Prostate Health Council. Urology. 1991 May;37(5):501.
  230. Quinlan DM, Epstein JI, Carter BS, Walsh PC . Sexual function following radical prostatectomy:influence of preservation of neurovascular bundles. J Urol. 1991 May;145(5):998-1002.
  231. Bastacky SS, Walsh PC , Epstein JI. Needle biopsy associated tumor tracking of adenocarcinoma of the prostate. J Urol. 1991 May;145(5):1003-7.
  232. Morton RA, Steiner MS, Walsh PC . Cancer control following anatomical radical prostatectomy:an interim report. J Urol. 1991 Jun;145(6):1197-200.
  233. Sadi MV, Walsh PC , Barrack ER. Immunohistochemical study of androgen receptors in metastatic prostate cancer. Comparison of receptor content and response to hormonal therapy. Cancer. 1991 Jun 15;67(12):3057-64.
  234. Carter, H.B. and Walsh, P.C.: Stage A1 prostatic adenocarcinoma. In Current Therapy in Genitourinary Surgery, 2nd Edition, (eds) Martin I. Resnick and Elroy D. Kursh; B.C. Decker, Mosby Year Book, Inc., St. Louis, MO, 1992, pp. 103-5.
  235. Hamper UM, Sheth S, Walsh PC , Holtz PM, Epstein JI. Stage B adenocarcinoma of the prostate:transrectal US and pathologic correlation of nonmalignant hypoechoic peripheral zone lesions. Radiology. 1991 Jul;180(1):101-4.
  236. Burgers JK, Nelson RJ, Quinlan DM, Walsh PC . Nerve growth factor, nerve grafts and amniotic membrane grafts restore erectile function in rats. J Urol. 1991 Aug;146(2):463- 8.
  237. Tempany CM, Rahmouni AD, Epstein JI, Walsh PC , Zerhouni EA. Invasion of the neurovascular bundle by prostate cancer:evaluation with MR imaging. Radiology. 1991 Oct;181(1):107-12.
  238. Ness PM, Walsh PC , Zahurak M, Baldwin ML, Piantadosi S. Prostate cancer recurrence in radical surgery patients receiving autologous or homologous blood. Transfusion. 1992 Jan;32(1):31-6.
  239. Ness PM, Bourke DL, Walsh PC . A randomized trial of perioperative hemodilution versus transfusion of preoperatively deposited autologous blood in elective surgery. Transfusion. 1992 Mar-Apr;32(3):226-30.
  240. Walsh PC . Why make an early diagnosis of prostate cancer. J Urol. 1992 Mar;147(3 Pt 2):853-4.
  241. Walsh, P.C.: Benign prostatic hyperplasia. In Campbell's Textbook of Urology, 6th Edition, (eds) Walsh, P.C., Retik, A.B., Stamey, T.A., and Vaughan, E.D., Jr.; W.B. Saunders, Philadelphia, 1992, Vol. 1, pp. 1009-27.
  242. Stutzman, R.E. and Walsh, M.D.: Suprapubic and retropubic prostatectomy. In Campbell's Textbook of Urology, 5th Edition, (eds) Walsh, P.C., Retik, A.B., Stamey, T.A., and Vaughan, E.D., Jr.; W.B. Saunders, Philadelphia, 1992, Vol. 3, pp. 2851-2864.
  243. Walsh, P.C.: Radical retropubic prostatectomy. In Campbell's Textbook of Urology, 6th Edition, (eds) Walsh, P.C., Retik, A.B., Stamey, T.A., and Vaughan, E.D., Jr.; W.B. Saunders, Philadelphia, 1992, Vol. 3, pp. 2865-86.
  244. Borland RN, Walsh PC . The management of rectal injury during radical retropubic prostatectomy. J Urol. 1992 Mar;147(3 Pt 2):905-7.
  245. Carter BS, Beaty TH, Steinberg GD, Childs B, Walsh PC . Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci U S A. 1992 Apr 15;89(8):3367-71.
  246. Carter HB, Pearson JD, Metter EJ, Brant LJ, Chan DW, Andres R, Fozard JL, Walsh PC . Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. JAMA. 1992 Apr 22-29;267(16):2215-20.
  247. Carter HB, Morrell CH, Pearson JD, Brant LJ, Plato CC, Metter EJ, Chan DW, Fozard JL, Walsh PC . Estimation of prostatic growth using serial prostate-specific antigen measurements in men with and without prostate disease. Cancer Res. 1992 Jun 15;52(12):3323-8.
  248. Epstein JI, Pizov G, Steinberg GD, Carter HB, Pitcock R, Armas OA, Partin A, Walsh PC. Correlation of prostate cancer nuclear deoxyribonucleic acid, size, shape and Gleason grade with pathological stage at radical prostatectomy. J Urol. 1992 Jul;148(1):87-91. Review.
  249. Walsh, P.C.: Radical retropubic prostatectomy: An anatomic approach. Campbell's Urology Sixth Edition, Update 1, pp. 1-13, 1992
  250. Brendler CB, Walsh PC . The role of radical prostatectomy in the treatment of prostate cancer. CA Cancer J Clin. 1992 Jul-Aug;42(4):212-22.
  251. Gormley GJ, Stoner E, Bruskewitz RC, Imperato-McGinley J, Walsh PC , McConnell JD, Andriole GL, Geller J, Bracken BR, Tenover JS, et al. The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group. N Engl J Med. 1992 Oct 22;327(17):1185-91.
  252. Rahmouni, A., Yang, A., Tempany, C.M.C., Frenkel, T., Epstein, J., Walsh, P., Leichner, P.K., Ricci, C. and Zerhouni, E.: Accuracy of in-vivo assessment of prostatic volume by MRI and transrectal ultrasonography. J. Computer Assisted Tomography 16:935-40.
  253. Burnett AL, Chan DW, Brendler CB, Walsh PC . The value of serum enzymatic acid phosphatase in the staging of localized prostate cancer. J Urol. 1992 Dec;148(6):1832-4.
  254. Walsh, P.C., Burnett, A.L., and Partin, A.W.: Anatomical radical retropubic prostatectomy: Evolution of the surgical technique. Highlights of the Audio-Visual Presentation, March 1993 Booklet, Creative Medical Communication, New York, NY.
  255. Tempany CM, Partin AW, Zerhouni EA, Zinreich SJ, Walsh PC . The influence of finasteride on the volume of the peripheral and periurethral zones of the prostate in men with benign prostatic hyperplasia. Prostate. 1993;22(1):39-42.
  256. Quinlan DM, Stutzman RE, Peters CA, Walsh PC . Unilateral nerve-sparing radical prostatectomy and hemicystectomy in management of prostate sarcoma. Urology. 1993 Apr;41(4):308-10.
  257. Walsh PC . The effect of finasteride in men with benign prostatic hyperplasia. J Urol. 1993 Apr;149(4):932-3.
  258. Bastacky SI, Walsh PC , Epstein JI. Relationship between perineural tumor invasion on needle biopsy and radical prostatectomy capsular penetration in clinical stage B adenocarcinoma of the prostate. Am J Surg Pathol. 1993 Apr;17(4):336-41.
  259. Epstein JI, Carmichael M, Walsh PC . Adenocarcinoma of the prostate invading the seminal vesicle:definition and relation of tumor volume, grade and margins of resection to prognosis. J Urol. 1993 May;149(5):1040-5.
  260. . Epstein JI, Carmichael M, Partin AW, Walsh PC . Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup. J Urol. 1993 Jun;149(6):1478-81.
  261. Epstein JI, Pizov G, Walsh PC . Correlation of pathologic findings with progression after radical retropubic prostatectomy. Cancer. 1993 Jun 1;71(11):3582-93.
  262. Partin AW, Yoo J, Carter HB, Pearson JD, Chan DW, Epstein JI, Walsh PC . The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol. 1993 Jul;150(1):110-4.
  263. Burnett AL, Tillman SL, Chang TS, Epstein JI, Lowenstein CJ, Bredt DS, Snyder SH, Walsh PC . Immunohistochemical localization of nitric oxide synthase in the autonomic innervation of the human penis. J Urol. 1993 Jul;150(1):73-6.
  264. Epstein JI, Carmichael MJ, Pizov G, Walsh PC . Influence of capsular penetration on progression following radical prostatectomy:a study of 196 cases with long-term followup. J Urol. 1993 Jul;150(1):135-41.
  265. Carter BS, Bova GS, Beaty TH, Steinberg GD, Childs B, Isaacs WB, Walsh PC . Hereditary prostate cancer:epidemiologic and clinical features. J Urol. 1993 Sep;150(3):797-802. Review.
  266. Bova GS, Carter BS, Bussemakers MJ, Emi M, Fujiwara Y, Kyprianou N, Jacobs SC, Robinson JC, Epstein JI, Walsh PC , et al. Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer. Cancer Res. 1993 Sep 1;53(17):3869-73.
  267. Cisek LJ, Walsh PC . Thromboembolic complications following radical retropubic prostatectomy. Influence of external sequential pneumatic compression devices. Urology. 1993 Oct;42(4):406-8.
  268. Walsh PC . A decision analysis of alternative treatment strategies for clinically localized prostate cancer. J Urol. 1993 Oct;150(4):1330-2.
  269. Walsh PC . Disease-specific survival following routine prostate cancer screening by digital rectal examination. J Urol. 1993 Oct;150(4):1328-9.
  270. Partin AW, Pound CR, Clemens JQ, Epstein JI, Walsh PC . Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years. Urol Clin North Am. 1993 Nov;20(4):713-25.
  271. Walsh, P.C.: Editorial - The heterogeneity of benign prostatic hyperplasia. J. Urol. 150:1587, 1993.
  272. Walsh PC . Using prostate-specific antigen to diagnose prostate cancer:sailing in uncharted waters. Ann Intern Med. 1993 Nov 1;119(9):948-9.
  273. Walsh PC , Partin AW. Treatment of early stage prostate cancer:radical prostatectomy. Important Adv Oncol. 1994;:211-23. Review.
  274. Gormley, G.J., Ng., J., Cook, T., Stoner, E., Guess, H. and Walsh, P.C.: Effect of finasteride on prostate-specific antigen density. Urol. 43:53-60, 1994.
  275. Schoenberg MP, Hakimi JM, Wang S, Bova GS, Epstein JI, Fischbeck KH, Isaacs WB, Walsh PC , Barrack ER. Microsatellite mutation (CAG24-->18) in the androgen receptor gene in human prostate cancer. Biochem Biophys Res Commun. 1994 Jan 14;198(1):74- 80.
  276. Epstein JI, Walsh PC , Carmichael M, Brendler CB. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA. 1994 Feb 2;271(5):368-74.
  277. Partin AW, Pearson JD, Landis PK, Carter HB, Pound CR, Clemens JQ, Epstein JI, Walsh PC . Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases. Urology. 1994 May;43(5):649-59.
  278. Epstein JI, Carmichael MJ, Partin AW, Walsh PC . Small high grade adenocarcinoma of the prostate in radical prostatectomy specimens performed for nonpalpable disease:pathogenetic and clinical implications. J Urol. 1994 Jun;151(6):1587-92.
  279. Partin AW, Lee BR, Carmichael M, Walsh PC , Epstein JI. Radical prostatectomy for high grade disease:a reevaluation 1994. J Urol. 1994 Jun;151(6):1583-6.
  280. Partin AW, Walsh PC . Re:The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol. 1994 Jul;152(1):172-3.
  281. Sanda MG, Beaty TH, Stutzman RE, Childs B, Walsh PC . Genetic susceptibility of benign prostatic hyperplasia. J Urol. 1994 Jul;152(1):115-9.
  282. Walsh, P.C.: Prostate Cancer Update, Vol. III, #1, Spring 1994 - Published by the James Buchanan Brady Urological Institute, The Johns Hopkins Hospital, Baltimore, Maryland 21287-2101.
  283. Walsh PC . Results of conservative management of clinically localized prostate cancer. J Urol. 1994 Jul;152(1):255-6.
  284. Walsh PC . Prostate cancer kills:strategy to reduce deaths. Urology. 1994 Oct;44(4):463- 6. Review.
  285. Walsh PC . Radical prostatectomy:a procedure in evolution. Semin Oncol. 1994 Oct;21(5):662-71. Review.
  286. Hedican SP, Walsh PC . Postoperative bleeding following radical retropubic prostatectomy. J Urol. 1994 Oct;152(4):1181-3.
  287. Walsh,P.C.: Technique of vesicourethral anastomosis may influence recovery of sexual function following radical prostatectomy. In Atlas of the Urologic Clinics of North America, vol. 2, #2, pp. 59-64, October 1994.
  288. Sgrignoli AR, Walsh PC , Steinberg GD, Steiner MS, Epstein JI. Prognostic factors in men with stage D1 prostate cancer:identification of patients less likely to have prolonged survival after radical prostatectomy. J Urol. 1994 Oct;152(4):1077-81.
  289. Partin AW, Page WF, Lee BR, Sanda MG, Miller RN, Walsh PC . Concordance rates for benign prostatic disease among twins suggest hereditary influence. Urology. 1994 Nov;44(5):646-50.
  290. Epstein JI, Walsh PC , Brendler CB. Radical prostatectomy for impalpable prostate cancer:the Johns Hopkins experience with tumors found on transurethral resection (stages T1A and T1B) and on needle biopsy (stage T1C) J Urol. 1994 Nov;152(5 Pt 2):1721-9. Review.
  291. Walsh PC , Partin AW, Epstein JI. Cancer control and quality of life following anatomical radical retropubic prostatectomy:results at 10 years. J Urol. 1994 Nov;152(5 Pt 2):1831- 6.
  292. Walsh PC . The status of radical prostatectomy in the United States in 1993:where do we go from here? J Urol. 1994 Nov;152(5 Pt 2):1816.
  293. Bastacky SI, Wojno KJ, Walsh PC , Carmichael MJ, Epstein JI. Pathological features of hereditary prostate cancer. J Urol. 1995 Mar;153(3 Pt 2):987-92.
  294. Carmichael MJ, Veltri RW, Partin AW, Miller MC, Walsh PC , Epstein JI. Deoxyribonucleic acid ploidy analysis as a predictor of recurrence following radical prostatectomy for stage T2 disease. J Urol. 1995 Mar;153(3 Pt 2):1015-9.
  295. Walsh, P.C.: Risk factors for prostate cancer: Is it possible to identify a high-risk population? In 4th International Symposium on Recent Advances in Urological Cancer Diagnosis and Treatment Proceeding, Paris, 1994, (eds) G. Murphy, S. Khoury, C. Chatelain, L. Denis, Scientific Communication International Ltd., Jersey, Cahnnel Islands, 1994, pp. 46-50.
  296. Walsh, P.C. and Epstein, J.I.: Radical prostatectomy and positive surgical margins: When, where, and what to do? In 4th International Symposium on Recent Advances in Urological Cancer diagnosis and Treatment Proceeding, Paris, 1994, (eds) G. Murphy, S. Khoury, C. Chatelain, L. Denis, Scientific Communicaton International Ltd., Jersey, Channel Islands, 1994, pp. 199-207.
  297. Walsh, P.C.: The natural history of localized prostate cancer: A guide to therapy. Campbell's Urology, Sixth Edition, Update 13, pp. 1-8, 1995.
  298. Carter HB, Pearson JD, Waclawiw Z, Metter EJ, Chan DW, Guess HA, Walsh PC . Prostate-specific antigen variability in men without prostate cancer:effect of sampling interval on prostate-specific antigen velocity. Urology. 1995 Apr;45(4):591-6.
  299. Partin AW, Piantadosi S, Sanda MG, Epstein JI, Marshall FF, Mohler JL, Brendler CB, Walsh PC , Simons JW. Selection of men at high risk for disease recurrence for experimental adjuvant therapy following radical prostatectomy. Urology. 1995 May;45(5):831-8.
  300. Berges RR, Vukanovic J, Epstein JI, CarMichel M, Cisek L, Johnson DE, Veltri RW, Walsh PC , Isaacs JT. Implication of cell kinetic changes during the progression of human prostatic cancer. Clin Cancer Res. 1995 May;1(5):473-80.
  301. Scher, H.I., Isaacs, J.T., Fuks, Z., and Walsh, P.C.: Prostate. In Clinical Oncology, 1995. (Eds) M.D. Abeloff, J.O. Armitage, A.S. Lichter, John E. Niederhuber, 1995, pp. 1439- 1472.
  302. Carter HB, Pearson JD, Metter EJ, Chan DW, Andres R, Fozard JL, Rosner W, Walsh PC. Longitudinal evaluation of serum androgen levels in men with and without prostate cancer. Prostate. 1995 Jul;27(1):25-31.
  303. Walsh PC . A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. J Urol. 1995 Jul;154(1):301.
  304. Polascik TJ, Walsh PC . Radical retropubic prostatectomy:the influence of accessory pudendal arteries on the recovery of sexual function. J Urol. 1995 Jul;154(1):150-2.
  305. Isaacs S.D, Kiemeney LA, Baffoe-Bonnie A, Beaty TH, Walsh PC . Risk of cancer in relatives of prostate cancer probands. J Natl Cancer Inst. 1995 Jul 5;87(13):991-6.
  306. Riopel, M.A., Polascik, T.J., Partin, A.W, Sauvageot, J., Walsh, P.C., and Epstein, J.I.: Radical prostatectomy in men less than 50 years old. Urol. Oncol. 1:80-83, 1995.
  307. Quinlan DM, Partin AW, Walsh PC . Can aggressive prostatic carcinomas be identified and can their natural history be altered by treatment? Urology. 1995 Sep;46(3 Suppl A):77-82. Review.
  308. Walsh PC . Re:Potency-sparing radical retropubic prostatectomy:a simplified anatomical approach. J Urol. 1996 Jan;155(1):294.
  309. Schoenberg MP, Walsh PC , Breazeale DR, Marshall FF, Mostwin JL, Brendler CB. Local recurrence and survival following nerve sparing radical cystoprostatectomy for bladder cancer:10-year followup. J Urol. 1996 Feb;155(2):490-4.
  310. Schoenberg M, Kiemeney L, Walsh PC , Griffin CA, Sidransky D. Germline translocation t(5;20)(p15;q11) and familial transitional cell carcinoma. J Urol. 1996 Mar;155(3):1035- 6.
  311. Epstein JI, Partin AW, Sauvageot J, Walsh PC . Prediction of progression following radical prostatectomy. A multivariate analysis of 721 men with long-term follow-up. Am J Surg Pathol. 1996 Mar;20(3):286-92.
  312. Partin AW, Criley SR, Subong EN, Zincke H, Walsh PC , Oesterling JE. Standard versus age-specific prostate specific antigen reference ranges among men with clinically localized prostate cancer:A pathological analysis. J Urol. 1996 Apr;155(4):1336-9.
  313. Xu J, Meyers D, Freije D, et al. Evidence for a prostate cancer susceptibility locus on the X chromosome. Nature Genetics 1998;20:175.
  314. Walsh PC . Campbell's Urology Update…21. Anatomic radical retropubic prostatectomy – an update after 2,000 cases.1997. W. B. Saunders Company
  315. Niesel T, Partin AW, Walsh PC . Anatomic approach for placement of surgical drains after radical retropubic prostatectomy:long-term effects on postoperative pain. Urology. 1996 Jul;48(1):91-4.
  316. Schlegel, P.N. and Walsh, P.C.: Preperitoneal hernia repair during urological surgery. In TEXTBOOK OF OPERATIVE UROLOGY, (eds) F.F. Marshall, L.R. Kavoussi, J.W. McAninch, C.A. Peters; W.B. Saunders Co., Philadelphia, 1996, pp. 381-85.
  317. Walsh PC . Follow-up prostate cancer treatments after radical prostatectomy:a population- based study. J Urol. 1996 Jul;156(1):301-2.
  318. Walsh PC . The definition and preoperative prediction of clinically insignificant prostate cancer. J Urol. 1996 Jul;156(1):300-1.
  319. Epstein JI, Walsh PC , Sanfilippo F. Clinical and cost impact of second-opinion pathology. Review of prostate biopsies prior to radical prostatectomy. Am J Surg Pathol. 1996 Jul;20(7):851-7.
  320. Walsh PC . Treatment of benign prostatic hyperplasia. N Engl J Med. 1996 Aug 22;335(8):586-7.
  321. Doehring CB, Sanda MG, Partin AW, Sauvageot J, Juo H, Beaty TH, Epstein JI, Hill G, Walsh PC . Histopathologic characterization of hereditary benign prostatic hyperplasia. Urology. 1996 Oct;48(4):650-3.
  322. Smith JR, Freije D, Carpten JD, Gronberg H, Xu J, Isaacs SD, Brownstein MJ, Bova GS, Guo H, Bujnovszky P, Nusskern DR, Damber JE, Bergh A, Emanuelsson M, Kallioniemi OP, Walker-Daniels J, Bailey-Wilson JE, Beaty TH, Meyers DA, Walsh PC , Collins FS, Trent JM, Isaacs WB. Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science. 1996 Nov 22;274(5291):1371-4.
  323. Partin, A.W. and Walsh, P.C.: Management of stage B (T1c-T2) Prostate Cancer. In Principles and Practice of Genitourinary Oncology (eds) D. Raghavan, H.I. Scher, S.A. Leibel, and P.H. Lange, Lippincott-Raven, Philadelphia, 1997, pp. 499-508.
  324. Pound CR, Walsh PC , Epstein JI, Chan DW, Partin AW. Radical prostatectomy as treatment for prostate-specific antigen-detected stage T1c prostate cancer. World J Urol. 1997;15(6):373-7.
  325. Walsh PC , Brooks JD. The Swedish prostate cancer paradox. JAMA. 1997 Feb 12;277(6):497-8.
  326. Sanda MG, Doehring CB, Binkowitz B, Beaty TH, Partin AW, Hale E, Stoner E, Walsh PC. Clinical and biological characteristics of familial benign prostatic hyperplasia. J Urol. 1997 Mar;157(3):876-9.
  327. Walsh PC . Re:Randomized, prospective, controlled study comparing radical prostatectomy alone and neoadjuvant androgen withdrawal in the treatment of localized prostate cancer. J Urol. 1997 Mar;157(3):965.
  328. Walsh PC . Is prostate cancer screening analogous to lung cancer screening? JAMA. 1997 Apr 9;277(14):1121; discussion 1121-2.
  329. Thiel R, Pearson JD, Epstein JI, Walsh PC , Carter HB. Role of prostate-specific antigen velocity in prediction of final pathologic stage in men with localized prostate cancer. Urology. 1997 May;49(5):716-20.
  330. Pound CR, Partin AW, Epstein JI, Walsh PC . Prostate-specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control. Urol Clin North Am. 1997 May;24(2):395-406.
  331. Walsh, P.C. and Worthington, J.F.: Prostate Cancer Update, vol IV, #1:1-16, Spring 1997.
  332. Walsh PC . Localized prostate cancer-mortality and morbidity. J Urol. 1997 May;157(5):1773.
  333. Partin AW, Kattan MW, Subong EN, Walsh PC , Wojno KJ, Oesterling JE, Scardino PT, Pearson JD. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA. 1997 May 14;277(18):1445-51.
  334. Carter HB, Sauvageot J, Walsh PC , Epstein JI. Prospective evaluation of men with stage T1C adenocarcinoma of the prostate. J Urol. 1997 Jun;157(6):2206-9. Review.
  335. Walsh, P.C.: Anatomic radical prostatectomy: Cancer control with preservation of quality of life. Presented at the General Motors Cancer Research Foundation Awards Ceremony, June 1996. Published in Accomplishments in Cancer Research 1996, (eds) Fortner, J.G., and Sharp, P.A., Lippincott-Raven Publishers, Philadelphia and New York, 1997, pp. 41- 53.
  336. Walsh, P.C.: The natural history of localized prostate cancer: A guide to therapy. In Campbell's Textbook of Urology, Seventh Edition, (eds) Walsh, P.C., Retik, A.B., Vaughan, Jr., E.D., and Wein, A.J.; W.B. Saunders, Phildelphia, 1997, pp. 2539-2546.
  337. Walsh, P.C.: Anatomic radical retropubic prostatectomy. In Campbell's Textbook of Urology, Seventh Edition, (eds) Walsh, P.C., Retik, A.B., Vaughan, Jr., E.D., and Wein, A.J., W.B. Saunders, Philadelphia, 1997, pp. 2565-2587.
  338. Cadeddu JA, Partin AW, Epstein JI, Walsh PC . Stage D1 (T1-3, N1-3, M0) prostate cancer:a case-controlled comparison of conservative treatment versus radical prostatectomy. Urology. 1997 Aug;50(2):251-5.
  339. Walsh PC . Screening for prostate cancer. American College of Physicians. J Urol. 1997 Oct;158(4):1617.
  340. Walsh PC . Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer:a multi-institutional update. J Urol. 1997 Oct;158(4):1618-9.
  341. Walsh PC . Immediate versus deferred treatment for advanced prostatic cancer:initial results of the Medical Research Council trial. The Medical Research Council Prostate Cancer Working Party Investigators Group. J Urol. 1997 Oct;158(4):1623-4.
  342. Gronberg H, Isaacs SD, Smith JR, Carpten JD, Bova GS, Freije D, Xu J, Meyers DA, Collins FS, Trent JM, Walsh PC , Isaacs WB. Characteristics of prostate cancer in families potentially linked to the hereditary prostate cancer 1 (HPC1) locus. JAMA. 1997 Oct 15;278(15):1251-5.
  343. Epstein JI, Walsh PC , Sauvageot J, Carter HB. Use of repeat sextant and transition zone biopsies for assessing extent of prostate cancer. J Urol. 1997 Nov;158(5):1886-90.
  344. Gronberg H, Xu J, Smith JR, Carpten JD, Isaacs SD, Freije D, Bova GS, Danber JE, Bergh A, Walsh PC , Collins FS, Trent JM, Meyers DA, Isaacs WB. Early age at diagnosis in families providing evidence of linkage to the hereditary prostate cancer locus (HPC1) on chromosome 1. Cancer Res. 1997 Nov 1;57(21):4707-9.
  345. Walsh, P.C.: The prostate and male pelvis. In The Johns Hopkins Atlas of Human Functional Anatomy. (ed) G.D. Zuidema, The Johns Hopkins University Press, Baltimore and London, 1997, pp. 155-156.
  346. Walsh PC , Partin AW. Family history facilitates the early diagnosis of prostate carcinoma. Cancer. 1997 Nov 1;80(9):1871-4.
  347. Page, W.F., Braun, M.M., Partin, A.W., Caporaso, N., and Walsh, P.C.: Heredity and prostate cancer: A study of World War II veteran twins. The Prostate 33:240-245, 1997.
  348. Walsh PC . Conflict of interest or widely held misconception? Urology. 1997 Dec;50(6):1028.
  349. McConnell, J.D., Bruske, R., Walsh, P.C., Andriole, G., Lieber, M., Holtgrewe, H.L., Albertsen, P., Roehrborn, C.G., Nickel, J.C., Wang, D.Z., Taylor, A.M., & Waldstreicher for the Finasteride Long-term Efficacy and Safety Study Group. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. NEJM 338:557-63, 1998.
  350. Walsh PC . Patient-reported impotence and incontinence after nerve-sparing radical prostatectomy. J Urol. 1998 Jan;159(1):308-9.
  351. Cadeddu JA, Partin AW, DeWeese TL, Walsh PC . Long-term results of radiation therapy for prostate cancer recurrence following radical prostatectomy. J Urol. 1998 Jan;159(1):173-7; discussion 177-8.
  352. Pannek J, Rittenhouse HG, Chan DW, Epstein JI, Walsh PC , Partin AW. The use of percent free prostate specific antigen for staging clinically localized prostate cancer. J Urol. 1998 Apr;159(4):1238-42. Review.
  353. Catalona WJ, Partin AW, Slawin KM, Brawer MK, Flanigan RC, Patel A, Richie JP, deKernion JB, Walsh PC , Scardino PT, Lange PH, Subong EN, Parson RE, Gasior GH, Loveland KG, Southwick PC. Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease:a prospective multicenter clinical trial. JAMA. 1998 May 20;279(19):1542-7.
  354. Polascik TJ, Pound CR, DeWeese TL, Walsh PC . Comparison of radical prostatectomy and iodine 125 interstitial radiotherapy for the treatment of clinically localized prostate cancer:a 7-year biochemical (PSA) progression analysis. Urology. 1998 Jun;51(6):884-9; discussion 889-90. Review.
  355. Glover FE Jr, Coffey DS, Douglas LL, Cadogan M, Russell H, Tulloch T, Baker TD, Wan RL, Walsh PC . The epidemiology of prostate cancer in Jamaica. J Urol. 1998 Jun;159(6):1984-6; discussion 1986-7.
  356. Walsh PC . Intermittent androgen deprivation for clinically localized prostate cancer:initial experience. J Urol. 1998 Jul;160(1):270-1.
  357. Walsh PC . Early age at diagnosis in families providing evidence of linkage to the hereditary prostate cancer locus (HPC1) on chromosome 1. J Urol. 1998 Jul;160(1):265- 6.
  358. Epstein JI, Pound CR, Partin AW, Walsh PC . Disease progression following radical prostatectomy in men with Gleason score 7 tumor. J Urol. 1998 Jul;160(1):97-100; discussion 101.
  359. Miller LR, Partin AW, Chan DW, Bruzek DJ, Dobs AS, Epstein JI, Walsh PC . Influence of radical prostatectomy on serum hormone levels. J Urol. 1998 Aug;160(2):449-53.
  360. Glover FE Jr, Coffey DS, Douglas LL, Russell H, Cadigan M, Tulloch T, Wedderburn K, Wan RL, Baker TD, Walsh PC . Familial study of prostate cancer in Jamaica. Urology. 1998 Sep;52(3):441-3.
  361. Bova GS, Partin AW, Isaacs SD, Carter BS, Beaty TL, Isaacs WB, Walsh PC . Biological aggressiveness of hereditary prostate cancer:long-term evaluation following radical prostatectomy. J Urol. 1998 Sep;160(3 Pt 1):660-3.
  362. Epstein JI, Chan DW, Sokoll LJ, Walsh PC , Cox JL, Rittenhouse H, Wolfert R, Carter HB. Nonpalpable stage T1c prostate cancer:prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findings. J Urol. 1998 Dec;160(6 Pt 2):2407-11. Review.
  363. Walsh PC . Anatomic radical prostatectomy:evolution of the surgical technique. J Urol. 1998 Dec;160(6 Pt 2):2418-24.
  364. Argani P, Walsh PC , Epstein JI. Analysis of the prostatic central zone in patients with unilateral absence of wolffian duct structures:further evidence of the mesodermal origin of the prostatic central zone. J Urol. 1998 Dec;160(6 Pt 1):2126-9.
  365. Eisenberger CF, Walsh PC , Eisenberger MA, Chow NH, Partin AW, Mostwin JL, Marshall FF, Epstein JI, Schoenberg M. Incidental non-Hodgkin's lymphoma in patients with localized prostate cancer. Urology. 1999 Jan;53(1):175-9.
  366. Walsh PC . Ten-year disease free survival after transperineal sonography-guided iodine- 125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high gleason grade prostate carcinoma. J Urol. 1999 Jan;161(1):357-8.
  367. Walsh PC . Treatment with finasteride preserves usefulness of prostate-specific antigen in the detection of prostate cancer:results of a randomized, double-blind, placebo-controlled clinical trial. J Urol. 1999 Jan;161(1):350-1.
  368. Holmes GF, Walsh PC , Pound CR, Epstein JI. Excision of the neurovascular bundle at radical prostatectomy in cases with perineural invasion on needle biopsy. Urology. 1999 Apr;53(4):752-6.
  369. Pound CR, Partin AW, Eisenberger MA, Chan DW, Pearson JD, Walsh PC . Natural history of progression after PSA elevation following radical prostatectomy. JAMA. 1999 May 5;281(17):1591-7.
  370. Wilkens EP, Freije D, Xu J, Nusskern DR, Suzuki H, Isaacs SD, Wiley K, Bujnovsky P, Meyers DA, Walsh PC , Isaacs WB. No evidence for a role of BRCA1 or BRCA2 mutations in Ashkenazi Jewish families with hereditary prostate cancer. Prostate. 1999 Jun 1;39(4):280-4.
  371. Feneley MR, Walsh PC . Incontinence after radical prostatectomy. Lancet. 1999 Jun 19;353(9170):2091-2.
  372. Pound CR, Christens-Barry OW, Gurganus RT, Partin AW, Walsh PC . Digital rectal examination and imaging studies are unnecessary in men with undetectable prostate specific antigen following radical prostatectomy. J Urol. 1999 Oct;162(4):1337-40.
  373. Southwick PC, Catalona WJ, Partin AW, Slawin KM, Brawer MK, Flanigan RC, Patel A, Richie JP, Walsh PC , Scardino PT, Lange PH, Gasior GH, Parson RE, Loveland KG. Prediction of post-radical prostatectomy pathological outcome for stage T1c prostate cancer with percent free prostate specific antigen:a prospective multicenter clinical trial. J Urol. 1999 Oct;162(4):1346-51.
  374. Epstein JI, Walsh PC , Akingba G, Carter HB. The significance of prior benign needle biopsies in men subsequently diagnosed with prostate cancer. J Urol. 1999 Nov;162(5):1649-52.
  375. Eisenberger MA, Walsh PC . Early androgen deprivation for prostate cancer? N Engl J Med. 1999 Dec 9;341(24):1837-8.
  376. Roehrborn CG, McConnell J, Bonilla J, Rosenblatt S, Hudson PB, Malek GH, Schellhammer PF, Bruskewitz R, Matsumoto AM, Harrison LH, Fuselier HA, Walsh PC , Roy J, Andriole G, Resnick M, Waldstreicher J. For the PLESS Study Group. Serum prostate specific antigen is a strong predictor of future prostate growth in men with benign prostatic hyperplasia. (Presented during 1998 American Urological Association Meeting, San Diego). J Urol 2000 Jan;163:13-20.
  377. Walsh PC , Marschke P, Ricker D, Burnett AL. Use of intraoperative video documentation to improve sexual function after radical retropubic prostatectomy. Urology. 2000 Jan;55(1):62-7.
  378. Walsh, P.C.: Prostate Cancer Update, Vol.V, #1, Winter 2000 - Published by the James Buchanan Brady Urological Institute, The Johns Hopkins Hospital, Baltimore, Maryland 21287-2101.
  379. Glover, F.E., Walsh, P.C., and Carter, H.B.: Epidemiology of prostate cancer in Jamaicans. In Advanced Therapy of Prostate Disease, (eds) Resnick, M.I. and Thompson, I.A., Hamilton & London, 2000, pp. 28-30.
  380. Walsh PC , Marschke P, Ricker D, Burnett AL. Patient-reported urinary continence and sexual function after anatomic radical prostatectomy. Urology. 2000 Jan;55(1):58-61.
  381. Walsh PC . Cancer surveillance series:interpreting trends in prostate cancer--part I:evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates. J Urol. 2000 Jan;163(1):364-5.
  382. Walsh PC . Sexual function and bother after radical prostatectomy or radiation for prostate cancer:multivariate quality-of-life analysis from CaPCURE. J Urol. 2000 Jan;163(1):370.
  383. Catalona WJ, Partin AW, Slawin KM, Naughton CK, Brawer MK, Flanigan RC, Richie JP, Patel A, Walsh PC , Scardino PT, Lange PH, deKernion JB, Southwick PC, Loveland KG, Parson RE, Gasior GH. Percentage of free PSA in black versus white men for detection and staging of prostate cancer:a prospective multicenter clinical trial. Urology. 2000 Mar;55(3):372-6.
  384. Walsh PC . Radical prostatectomy for localized prostate cancer provides durable cancer control with excellent quality of life:a structured debate. J Urol. 2000 Jun;163(6):1802-7.
  385. Rodriguez R, Walsh PC . Trousseau's syndrome in a patient with metastatic prostate cancer. J Urol. 2000 Jun;163(6):1877.
  386. Han M, Walsh PC , Partin AW, Rodriguez R. Ability of the 1992 and 1997 American Joint Committee on Cancer staging systems for prostate cancer to predict progression- free survival after radical prostatectomy for stage T2 disease. J Urol. 2000 Jul;164(1):89- 92.
  387. . Walsh PC . Patient-reported urinary continence and sexual function after anatomic radical prostatectomy. J Urol. 2000 Jul;164(1):242.
  388. Walsh PC . Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer. J Urol. 2000 Jul;164(1):246-7.
  389. Catalona WJ, Southwick PC, Slawin KM, Partin AW, Brawer MK, Flanigan RC, Patel A, Richie JP, Walsh PC , Scardino PT, Lange PH, Gasior GH, Loveland KG, Bray KR. Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging. Urology. 2000 Aug 1;56(2):255-60.
  390. Epstein JI, Partin AW, Potter SR, Walsh PC . Adenocarcinoma of the prostate invading the seminal vesicle:prognostic stratification based on pathologic parameters. Urology. 2000 Aug 1;56(2):283-8.
  391. Walsh PC . Re:radiotherapy for isolated serum prostate specific antigen elevation after prostatectomy for prostate cancer. J Urol. 2000 Oct;164(4):1322-3.
  392. Chan TY, Partin AW, Walsh PC , Epstein JI. Prognostic significance of Gleason score 3+4 versus Gleason score 4+3 tumor at radical prostatectomy. Urology. 2000 Nov 1;56(5):823-7.
  393. Feneley MR, Landis P, Simon I, Metter EJ, Morrell CH, Carter HB, Walsh PC . Today men with prostate cancer have larger prostates. Urology. 2000 Nov 1;56(5):839-42.
  394. Bahnson RR, Hanks GE, Huben RP, Kantoff P, Kozlowski JM, Kuettel M, Lange PH, Logothetis C, Pow-Sang JM, Roach M 3rd, Sandler H, Scardino PT, Taylor RJ, Urban DA, Walsh PC , Wilson TG. NCCN Practice Guidelines for Prostate Cancer. Oncology (Huntingt). 2000 Nov;14(11A):111-9.
  395. Blute ML, Bergstralh EJ, Partin AW, Walsh PC , Kattan MW, Scardino PT, Montie JE, Pearson JD, Slezak JM, Zincke H. Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer. J Urol. 2000 Nov;164(5):1591-5.
  396. Potter SR, Mangold LA, Shue MJ, Taylor DC, Lecksell KL, Epstein JI, Walsh PC , Partin AW. Molecular and immunohistochemical staging of men with seminal vesicle invasion and negative pelvic lymph nodes at radical prostatectomy. Cancer. 2000 Dec 15;89(12):2577-86.
  397. Han M, Snow PB, Epstein JI, Chan TY, Jones KA, Walsh PC , Partin AW. A neural network predicts progression for men with gleason score 3+4 versus 4+3 tumors after radical prostatectomy. Urology. 2000 Dec 20;56(6):994-9.
  398. Walsh PC . Modern prostate brachytherapy:prostate specific antigen results in 219 patients with up to 12 years of observed follow-up. J Urol. 2001 Jan;165(1):318-9.
  399. Walsh PC , Marschke P, Catalona WJ, Lepor H, Martin S, Myers RP, Steiner MS. Efficacy of first-generation Cavermap to verify location and function of cavernous nerves during radical prostatectomy:a multi-institutional evaluation by experienced surgeons. Urology. 2001 Mar;57(3):491-4.
  400. Han M, Pound CR, Potter SR, Partin AW, Epstein JI, Walsh PC . Isolated local recurrence is rare after radical prostatectomy in men with Gleason 7 prostate cancer and positive surgical margins:therapeutic implications. J Urol. 2001 Mar;165(3):864-6.
  401. Walsh PC . Letter to the Editor: Re: Radical prostatectomy:the value of preoperative, individually labeled apical biopsies. J Urol. 2001 Mar;165(3):915.
  402. Han M, Piantadosi S, Zahurak ML, Sokoll LJ, Chan DW, Epstein JI, Walsh PC , Partin AW. Serum acid phosphatase level and biochemical recurrence following radical prostatectomy for men with clinically localized prostate cancer. Urology. 2001 Apr;57(4):707-11.
  403. Xu J, Zheng SL, Chang B, Smith JR, Carpten JD, Stine OC, Isaacs SD, Wiley KE, Henning L, Ewing C, Bujnovszky P, Bleeker ER, Walsh PC , Trent JM, Meyers DA, Isaacs WB. Linkage of prostate cancer susceptibility loci to chromosome 1. Hum Genet. 2001 Apr;108(4):335-45.
  404. Xu J, Zheng SL, Carpten JD, Nupponen NN, Robbins CM, Mestre J, Moses TY, Faith DA, Kelly BD, Isaacs SD, Wiley KE, Ewing CM, Bujnovszky P, Chang B, Bailey- Wilson J, Bleecker ER, Walsh PC , Trent JM, Meyers DA, Isaacs WB. Evaluation of linkage and association of HPC2/ELAC2 in patients with familial or sporadic prostate cancer. Am J Hum Genet. 2001 Apr;68(4):901-11.
  405. Zheng SL, Xu J, Isaacs SD, Wiley K, Chang B, Bleecker ER, Walsh PC , Trent JM, Meyers DA, Isaacs WB. Evidence for a prostate cancer linkage to chromosome 20 in 159 hereditary prostate cancer families. Hum Genet. 2001 May;108(5):430-5.
  406. Epstein JI, Walsh PC , Carter HB. Importance of posterolateral needle biopsies in the detection of prostate cancer. Urology. 2001 Jun;57(6):1112-1116.
  407. Walsh PC . Nerve grafts are rarely necessary and are unlikely to improve sexual function in men undergoing anatomic radical prostatectomy. Urology. 2001 Jun;57(6):1020-1024.
  408. Roberts WW, Bergstralh EJ, Blute ML, Slezak JM, Carducci M, Han M, Epstein JI, Eisenberger MA, Walsh PC , Partin AW. Contemporary identification of patients at high risk of early prostate cancer recurrence after radical retropubic prostatectomy. Urology. 2001 Jun;57(6):1033-1037.
  409. Walsh PC , DeWeese TL, Eisenberger MA. A structured debate: immediate versus deferred androgen suppression in prostate cancer-evidence for deferred treatment. J Urol. 2001 Aug;166(2):508-15; discussion 515-6.
  410. Han M, Partin AW, Piantadosi S, Epstein JI, Walsh PC . Era specific biochemical recurrence-free survival following radical prostatectomy for clinically localized prostate cancer. J Urol. 2001 Aug;166(2):416-9.
  411. Xu J, Zheng SL, Hawkins GA, Faith DA, Kelly B, Isaacs SD, Wiley KE, Chang B, Ewing CM, Bujnovszky P, Carpten JD, Bleecker ER, Walsh PC , Trent JM, Meyers DA, Isaacs WB. Linkage and association studies of prostate cancer susceptibility:evidence for linkage at 8p22-23. Am J Hum Genet. 2001 Aug;69(2):341-50.
  412. Han, M., Partin, A.W., Pound, C.R., Epstein, J.I., Walsh, P.C.: Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy - The 15-year Johns Hopkins experience. Urologic Clinics of N. America 2001 Aug;28(3)555-65.
  413. Epstein, J.I., Walsh, P.C., and Carter, H.B.: Dedifferentiation of prostate cancer grade with time in men followed expectantly for stage T1c disease. J. Urol. 2001 Nov;1688-91.
  414. Chang B., Zheng SL, Isaacs, SD, Wiley KE, Carpten JD, Hawkins GA, Bleecker ER, Walsh PC , Trent JM, Meyers DA, Isaacs WB, Xu J. Linkage and association of CYP17 gene in hereditary and sporadic prostate cancer. Int. J. Cancer 2001 Nov 20;95(6):354-9.
  415. Barocas DA, Han M, Epstein, JI, Chan, DY, Trock BJ, Walsh PC , Partin AW. Does capsular incision at radical retropubic prostatectomy affect disease-free survival in otherwise organ-confined prostate cancer? Urology. 2001 Nov;58(5):746-51.
  416. Partin AW, Mangold LA, Lamm DM, Walsh PC , Epstein JI, Pearson JD. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. Urology. 2001 Dec;58(6):843-8.
  417. Carpten J, Nupponen N, Isaacs S, Sood R, Robbins C, Xu J, Faruque M, Moses T, Ewing C, Gillanders E, Hu P, Bujnovszky P, Makalowska I, Baffoe-Bonnie A, Faith D, Smith J, Stephen D, Wiley K, Brownstein M, Gildea D, Kelly B, Jenkins R, Hostetter G, Matikainen M, Schleutker J, Klinger K, Connors T, Xiang Y, Wang Z, De Marzo A, Papadopoulos N, Kallioniemi O-P, Burk R, Meyers D, Gronberg H, Meltzer P, Silverman R, Bailey-Wilson J, Walsh P, Isaacs W, Trent J. Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nature Genetics 2002 Jan;1-3.
  418. Gormley GJ, Stoner E., Bruskewitz RC, Imperato-McGinley J, Walsh PC , McConnell, JD, Andriole, GL, Geller J, Bracken BR, Tenover JS, Binkowitz B, Ng J.: The effect of finasteride in men with benign prostatic hyperplasia. J Urol 2002;167(2 Pt 2):1102. 418a. Chang B-l, Zheng SL, Hawkins GA, Isaacs SD, Wiley KE, Turner A, Carpten JD, Bleecker ER, Walsh PC , Trent JM, Meyers DA. Polymorphic GGC repeats in the androgen receptor gene are associated with hereditary and sporadic prostate cancer risk. Hum Genet 2002;110:122-129.
  419. O'Malley KJ, Pound CR, Walsh PC , Epstein JI, Partin, AW. Influence of biopsy perineural invasion on long-term biochemical disease-free survival after radical prostatectomy. UROLOGY 2002;59(1):85-90.
  420. Walsh PC and Donker PJ: Impotence following radical prostatectomy: Insight into etiology and prevention. J Urol Feb.2002;167:1005-1010.
  421. Chang B-l, Zheng SL, Hawkins GA, Isaacs SD, Wiley KE, Turner A, Carpten JD, Bleecker ER, Walsh PC , Trent JM, Meyers DA, Isaacs WB. Joint effect of HSD3B1 and HSD3B2 genes is associated with hereditary and sporadic prostate cancer susceptibility1 Cancer Research 15 March2002;62:1784-1789.
  422. Carter HB, Walsh PC , Landis P, Epstein JI. Expectant management of nonpalpable prostate cancer with curative intent: preliminary results. J. Urol. 2002 Mar;167;1231-34.
  423. Ho, GYF, Knapp M, Freue D, Nelson WG, Smith JR, Carpten JD, Bailey-Wilson JE, Beaty TH, Petersen G, Xu Jianfeng, Kamensky V, Walsh PC , Isaacs WB: Transmission/disequilibrium tests of androgen receptor and glutathione S-transferase PI variants in prostate cancer families. Int. J. Cancer 2002;98;938-942
  424. Xu J, Zheng SL, Turner A, Isaacs SD, Wiley KE, Hawkins GA, Chang B-l, Bleecker ER, Walsh PC , Meyers DA, Isaacs WB.: Associations between h0GG1 sequence variants and prostate cancer susceptibility1. Cancer Research 2002;62, 2253-2257
  425. Walsh, P.C., Marschke, PL.: Intussusception of the reconstructed bladder neck leads to earlier continence after radical prostatectomy. Urology 2002;59:934-938.
  426. Walsh, PC. Anatomic radical retropubic prostatectomy. In Campbell's Textbook of Urology, Eighth Edition, (eds) Walsh, P.C., Retik, A.B., Vaughan, Jr., E.D., and Wein, A.J., W.B. Saunders, Philadelphia, 2002, pp. 3107-3129.
  427. Walsh, P.C.: Surgery and the reduction of mortality from prostate cancer. N Engl J Med. 2002;347:839-840. Editorial.
  428. Hawkins GA, Mychaleckyj JC, Zheng SL, Faith DA, Kelly B, Isaacs SD, Wiley KE, Chang B-L, Ewing CM, Bujnovszky P, Bleecker ER, Walsh PC , Meyers DA, Isaacs WB, Xu J.: Germline sequence variants of the LZTS1 gene are associated with prostate cancer risk. Cancer Genetics and Cytogenetics 2002 Aug; 137:1-7.
  429. Gretzer, M.B, Trock BJ, Han M, Walsh PC : A critical analysis of the interpretation of biochemical failure in surgically treated patients using the American Society for therapeutic radiation and oncology criteria. J Urol. 2002 Oct;168:1419-1422.
  430. Xu J, Zheng SL, Komiya A., Mychaleckyj JC, Isaacs SD, Hu JJ, Sterling D, Lange EM, Hawkins GA, Turner A, Ewing CM, Faith DA, Johnson JR, Suzuki H, Bujnovszky P, Wiley KE, DeMarzo AM, Bova GS, Chang B, Hall MC, McCullough DL, Partin AW, Kassabian VS, Carpten JD, Bailey-Wilson JE, Trent JM, Ohar J, Bleecker ER, Walsh PC , Isaacs WB, Meyers DA. Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk. Nature Genetics 2002 Oct;32:321-325.
  431. Hawkins GA, Cramer SD, Zheng SL, Isaacs SD, Wiley KE, Chang BL, Bleecker ER, Walsh PC , Meyers DA, Isaacs WB, Xu J.: Sequence variants in the human 25- hydroxyvitamin D3 1-alpha-hydroxylase (CYP27B1) gene are not associated with prostate cancer risk. Prostate 2002 Nov 1;53:175-178.
  432. Zheng SL, Chang B-l, Faith DA, Johnson JR, Isaacs SD, Hawkins GA, Turner A, Wiley KE, Bleecker ER, Walsh PC , Meyers DA, Isaacs WB, Xu J.: Sequence variants of á- methylacyl-CoA racemase are associated with prostate cancer risk. Cancer Research 2002 Nov,62:6485-6488.
  433. Gretzer MB, Epstein JI, Pound CR, Walsh PC , Partin AW: Substratification of stage T1c prostate cancer based on the probability of biochemical recurrence. Urology 2002 Dec 60:1034-1039.
  434. Walsh, P.C.: Prostate and renal cancer, benign prostatic hyperplasia, erectile dysfunction and basic research - an update. In The Proceedings of the VII Congress on Progress and Controversies in Oncological Urology (PACIOU VII) and the Seventh Congress of the Dutch Urological Association, (eds) Bangma, Ch. H., and Newling D.W.W., Boca Raton, London, New York, Washington, D.C. 2002:280-284.
  435. Walsh P.C.: Prostate Cancer Update, Vol.VI, #1, Winter 2003 - Published by the James Buchanan Brady Urological Institute, The Johns Hopkins Hospital, Baltimore, Maryland 21287-2101.
  436. Jianfeng Xu, Zheng SL, Komiya A, Mychaleckyj JC, Isaacs SD, Chang B, Turner AR, Ewing CM, Wiley KE, Hawkins GA, Bleecker ER, Walsh PC , Meyers DA, Isaacs WB.: Common sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk. Am. J. Hum. Genet. 2003; 72:208-212.
  437. Han M, Partin AW, Zahurak M, Piantadosi S, Epstein JI, Walsh PC : Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. J. Urol. 2003 Feb;169:517-523.
  438. Roberts WW, Platz EA, Walsh PC : Association of cigarette smoking with extraprostatic prostate cancer in young men. J Urol 2003 Feb;169:512-516.
  439. Gonzalgo ML, Walsh PC : Balloon cuffing and management of the entrapped Foley catheter. Urology 2003 Apr;61:826-827.
  440. Rohrmann S, Roberts WW, Walsh PC , Platz EA: Family history of prostate cancer and obesity in relation to high-grade disease and extraprostatic extension in young men with prostate cancer. The Prostate 2003;55:140-146..
  441. Khan MA, Han M, Partin AW, Epstein JI, Walsh PC : Long-term cancer control of radical prostatectomy in men younger than 50 years of age: Update 2003. UROLOGY 2003;62:86-92.
  442. Pearson JD, L H-H, Beaty TH, Wiley K, Isaacs SD, Isaacs WB, Stoner E, Walsh PC : Familial aggregation of bothersome benign prostatic hyperplasia symptoms. UROLOGY 2003, 61:781-785.
  443. Lowe FC, McConnell JD, Hudson PB, Romas NA, Boake R, Lieber M, Elhilali M, Geller J, Imperto-McGinely J, Andriole, GL, Bruskewitz RC, Walsh PC , Bartsch G, Nacey JN, Shah S, Papa F, Ko A, Cook T, Stoner E, Waldstreicher J; Finasteride Study Group. Long-term 6-year experience with finasteride in patients with benign prostatic hyperplasia. Urology 2003 Apr;61(4):791-6.
  444. Chang B-l, Zheng SL, Isaacs SD, Turner AR, Bleecker ER, Walsh PC , Meyers DA, Isaacs WB, Xu J.: Evaluation of SRD5A2 sequence variants in susceptibility to hereditary and sporadic prostate cancer. The Prostate 2003;56:37-44.
  445. Chang BL, Zheng SD, Isaacs SL, Turner AR, Hawkins GA, Wiley KE, Bleecker ER, Walsh PC , Meyers DA, Isaacs WB, Xu J.: Polymorphisms in the CYP 1 B1 gene are associated with increased risk of prostate cancer. Brit. J. Cancer 2003;89:1524-1529.
  446. Luo J, Dunn TA, Ewing CM, Walsh PC , Isaacs WB: Decreased gene expression of steroid 5 alpha-reductase 2 in human prostate cancer: implicatioins for finasteride therapy of prostate carcinoma. The Prostate 2003;57:134-139.
  447. XU J, Gillanders EM, Isaacs SD, Chang BL, Wiley KE, Zheng SL, Jones MP, Gildea D, Riedesel E, Albertus J, Freas-Lutz D, Markey C, Meyers DA, Walsh PC , Trent JM, Isaacs WB: Genome-wide scan for prostate cancer susceptibility genes in the Johns Hopkins hereditary prostate cancer families. The Prostate 2003;57:320-325.
  448. Khan MA, Carter HB, Epstein JI, Miller MC, Landis P, Walsh PC , Partin AW, Veltri RW: Can prostate specific antigen derivatives and pathological parameters predict significant change in expectant management criteria for prostate cancer? J. Urol. 2003;170:2274-2278.
  449. Khan MA, Partin AW, Mangold LA, Epstein JI, Walsh PC : Probability of biochemical recurrence by analysis of pathologic stage, Gleason score, and margin status for localized prostate cancer. UROLOGY 2003;62:866-871.
  450. Zheng SL, Mychaleckyj JC, Hawkins GA, Isaacs SD, Wiley KE, Turner A, Chang B-l, von Kap-Herr C, Carpten JD, Pettenati M, Bleecker EU, Walsh PC , Trent JM, Meyers DA, Isaacs WB, Xu J.: Evaluation of DLC1 as a prostate cancer susceptibilty gene; mutation screen and association study. Mutation Research 2003;528:45-53.
  451. Khan MA, Walsh PC , Miller MC, Bales WD, Epstein JI, Mangold LA, Partin AW, RW. Quantitative alterations in nuclear structure predict prostate carcinoma distant metastasis and death in men with biochemical recurrence after radical prostatectomy. Cancer 2003;98(12):2583-2591.
  452. Han M, Partin AW, Chan DY, Walsh PC : An evaluation of the decreasing incidence of positive surgical margins in a large retropubic prostatectomy series. J. Urol.2004;171:23- 26.
  453. Brown WH, Lange EM, Chen H, Zheng SL, Chang B, Wiley KE, Isaacs SD, Walsh PC , Isaacs WB, Xu J, Cooney KA. Hereditary prostate cancer in African American families: linkage analysis using markers that map to five candidate susceptibility loci. Brit. J. CA 2004;90:510-514.
  454. Friedrichsen DM, Stanford JL, Isaacs SD, Janer M, Chang B-l, Deutsch K, Gillanders E, Kolb S, Wiley KE, Badzioch MD, Zheng SL, Walsh PC , Jarvik GP, Hood L, Trent JM, Isaacs WB, Ostrander EA, Xu J: Identification of a prostate cancer susceptibility locus on chromosome 7q11-21 in Jewish families. PNAS 2004;101:1939-1944.
  455. Carter HB, Metter E J, Wright J, Landis P, Platz E, and Walsh PC . Prostate-specific antigen and all-cause mortality: Results from the Baltimore Longitudinal Study of Aging, JNCI 2004;96:557-558.
  456. Schaeffer EM, and Walsh PC : Risks of testosterone replacement. Letter to the Editor, NEJM 2004(May);350:19
  457. Xu, J., Langefeld, C.D., Zheng, S.L., Gillanders, E.M., Chang, B-l, Isaacs, S.D., Williams, A.H., Wiley, K.E., Dimitrov, L., Meyers, D.A., Walsh, P.C., Trent, J.M., Isaaacs W.B.: Interaction effect of PTEN and CDKN1B chromosomal regions on prostate cancer linkage. Hum Genetics 2004(Aug);115(3):255-262.
  458. Schaeffer EM, Epstein JI, and Walsh PC : Amyloidosis of the Seminal vesicle and hematospermia. J. Urol. 2004;171:2382.
  459. Veltri RW, Khan MA, Miller MC, Epstein JI, Mangold LA, Walsh PC , Partin AW: Ability to predict metastasis based on pathology findings and alterations in nuclear structure of normal-appearing and cancer peripheral zone epithelium in the prostate. Clinical Cancer Research 2004;10:3465-3473.
  460. Hawkins GA, Bao-Li C, Zheng SL, Isaacs SD, Wiley KE, Bleecker ER, Walsh PC , Meyers DA, Xu J, and Isaacs WB. Mutational analysis of PINXI in hereditary prostate cancer. The Prostate 2004;60:298-302.
  461. Rogers CG, Trock BP, Walsh PC : Preservation of accessory pudendal arteries during radical retropubic prostatectomy: Surgical technique and results. Urology 2004;64:148- 151.
  462. Yegnasubramanian S, Kowalski J, Gonzalgo ML, Zahurak M, Piantadosi S, Walsh PC , Bova GS, DeMarzo AM, Isaacs WB, Nelson WG: Hypermethylation of CpG islands in primary and metastatic human prostate cancer. Cancer Research 2004;64:1975-1986.
  463. Freedland SJ, Partin AW, Epstein JI, Walsh PC : Biochemical failure after radical prostatectomy in men with pathologic organ-confined disease: pT2a versus pT2b. Cancer 2004 April;100(8):1646-1649.
  464. Gillanders EM, Xu J, Chang B-l, Lange EM, Wiklund F, Bailey-Wilson JE, Baffoe- Bonnie A., Jones MP, Gildea D, Riedesell E, Albertus J, Isaacs SD, Wiley KE, Mohai CE, Matikainen MP, Teuvo LJT, Zheng SL, Brown WM, Rokman An, Carpten JD, Meyers DA, Walsh PC , Schleutker J, Gronberg H, Cooney KA, Isaacs WB, Trent JM: Combined genome-wide scan for prostate cancer susceptibility genes. JNCI 2004;96:1240-1247.
  465. Walsh PC : Anatomic Radical Retropubic Prostatectomy: Detailed Description of the Surgical Technique. Foreword to DVD 2004.
  466. Ong AM, Su L-M, Varkarakis I, Inagaki T, Link RE, Bhayani SB, Patriciu A, Crain B, and Walsh PC : Nerve sparing radical prostatectomy: Effects of hemostatic energy sources on the recovery of cavernous nerve function in a canine model. J. Urol. 172:1318-1322, 2004.
  467. Aydin H, Tsuzuki T, Hernandez D, Walsh PC , Partin, AW, and Epstein JI: Positive proximal (bladder neck) margin at radical prostatectomy confers greater risk of biochemical progression. UROLOGY64:551-555, 2004.
  468. Parsons JK, Marschke P, Maples P, and Walsh PC : Effect of methylprednisolone on return of sexual function after nerve-sparing radical retropubic prostatectomy. UROLOGY 64:987-990, 2004.
  469. Khan MA, Mangold LA, Epstein JI, Boitnott JK, Walsh PC , Partin AW: Impact of surgical delay on long-term cancer control for clinically localized prostate cancer. J. Urol. 172:1835-1839, 2004
  470. Faith, DA, Isaacs, WB, Morgan JD, Fedor HL, Hicks JL, Mangold LA, Walsh, PC, Partin AW, Platz, EA, Luo J, DeMarzo AM.: Trefoil factor 3 overexpression in prostatic carcinoma: Prognostic importance using Tissue Microarrays. The Prostate 61:215-227, 2004.
  471. Allaf ME, Palapattu GS, Trock BJ, Carter HB, and Walsh PC : Anatomical extent of lymph node dissection: Impact on men with clinically localized prostate cancer. J. Urol. 172:1840-1844, 2004
  472. Palapattu GS, Allaf ME, Trock BJ, Epstein JI, and Walsh PC : Prostate specific antigen progression in men with lymph node metastases following radical prostatectomy: results of long-term followup. J. Urol. 172:1860-1864, 2004.
  473. Hernandez DJ, Epstein JI, Trock BJ, Tsuzuki T, Carter HB, Walsh PC : Radical retropubic prostatectomy. How often do experienced surgeons have positive surgical margins when there is extraprostatic extension in the region of the neurovascular bundle? J. Urol. 173:446-449, 2005
  474. Tsuzuki T, Hernandez DJ, Aydin H, Trock B, Walsh PC , Epstein JI: Prediction of extraprostatic extension in the neurovascular bundle based on prostate needle biopsy pathology, serum prostate specific antigen and digital rectal examination. J. Urol. 173:450-453, 2005.
  475. Narla G, Difeo A, Reeves HL, Schaid DJ, Hirshfeld J, Hod E, Katz A, Isaacs WB, Hebbring S, Komiya A, McDonnel SK, Wiley, Jacobsen SJ, Isaacs SD, Walsh, PC, Zheng SL, Chang BL, Friedrichsen DM, Stanford JL, Ostrander EA, Chinnaiyan AM, Rubin MA, Xu J, Thibodeau SN, Friedman SL, Martignetti JA. A germline DNA polymorphism enhances alternative splicing of the KLF6 tumor suppressor gene and is associated with increased prostate cancer risk. Cancer Res. 65(4):1213-1222, Feb. 2005.
  476. Freedland SJ, Isaacs WB, Mangold L, Yiu SK, Grubb KA, Partin AW, Epstein JI, Walsh PC, Platz EA.: Stronger association between obesity and biochemical progression following radical prostatectomy among men treated in the last 10 years. Clin. Cancer Res 11(8):2883-2888, 2005.
  477. Xu, J., Dimitrov, L., Chang, B-L., Adams, S. et al: A combined genomewide linkage scan, of 1,233 families, for prostate cancer-susceptibility genes conducted by the International Consortium for prostate cancer genetics. Am. J. Hum. Genet 77:219-229, 2005
  478. Freedland, S.J., Humphreys, E.G., Mangold, L.A., Eisenberger, M., Dorey, F.J., Walsh, P.C., and Partin, A.W.: Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy. JAMA 294(4):433-439, 2005.
  479. Xu, J., Dimitrov, L., Chang, B-L., Adams, S. et al: A combined genomewide linkage scan, of 1,233 families, for prostate cancer-susceptibility genes conducted by the International Corsortium for prostate cancer genetics. Am. J. Hum. Genet 77:219-229, 2005.
  480. Wu CL, Partin AW, Rowlingson AJ, Kalish MA, Walsh PC , Fleisher LA. Efficacy of continuous local anesthetic infusion for postoperative pain after radical retropubic prostatectomy.Urology. 2005 Aug;66(2):366-70.
  481. Chang BL, Isaacs SD, Wiley KE, Gillanders EM, Zheng SL, Meyers DA, Walsh PC , Trent JM, Xu J, Isaacs WB. Genome-wide screen for prostate cancer susceptibility genes in men with clinically significant disease. Prostate. 2005 Sep 1;64(4):356-61.
  482. Freedland SJ, Mangold LA, Walsh PC , Partin AW. The prostatic specific antigen era is alive and well: prostatic specific antigen and biochemical progression following radical prostatectomy. J Urol. 2005 Oct;174(4 Pt 1):1276-81
  483. Nielsen ME, Walsh PC . Systematic detection and repair of subclinical inguinal hernias at radical retropubic prostatectomy.Urology. 2005 Nov;66(5):1034-7.
  484. Wu CL, Rowlingson AJ, Partin AW, Kalish MA, Courpas GE, Walsh PC , Fleisher LA Correlation of postoperative pain to quality of recovery in the immediate postoperative period. Reg Anesth Pain Med. 2005 Nov-Dec;30(6):516-22.
  485. Chang BL, Lange EM, Dimitrov L, Valis CJ, Gillanders EM, Lange LA, Wiley KE, Isaacs SD, Wiklund F, Baffoe-Bonnie A, Langefeld CD, Zheng SL, Matikainen MP, Ikonen T, Fredriksson H, Tammela T, Walsh PC , Bailey-Wilson JE, Schleutker J, Gronberg H, Cooney KA, Isaacs WB, Suh E, Trent JM, Xu J. Two-locus genome-wide linkage scan for prostate cancer susceptibility genes with an interaction effect. Human Genet. 2005 Nov 23;1-9.
  486. Xu J, Lowey J, Wiklund F, Sun J, Lindmark F, Hsu F-C, Dimitrov L, Chang B, Turner AR, Liu W, Adami H-O, Suh E, Moore JH, Zheng SL, Isaacs WB, Trent JM, Gronberg H. The interaction of four genes in the inflammation pathway significantly predicts prostate cancer risk. Cancer Epidemiol. Biomarkers Prev 2005;14(11)2563-2568.
  487. Zheng SL, Ju JH, Chang BL, Ortner E, Sun J, Isaacs SD, Sun J, Wiley KE, Liu W, Zemedkun M, Walsh PC , Ferretti J, Gruschus J, Isaacs WB, Gelmann EP, Xu J. Germ- Line Mutation of NKX3.1 Cosegregates with hereditary prostate cancer and alters the homeodomain structure and function. Cancer Res. 2006 Jan 1;66(1):69-77.
  488. Gonzalgo ML, Bastian PJ, Mangold LA, Trock BJ, Epstein JI, Walsh PC , Partin, AW. Relationship between primary Gleason pattern on needle biopsy and clinicopathologic outcomes among men with Gleason score 7 adenocarcinoma of the prostate. UROLOGY 2006;67(1):115-119.
  489. Rohrmann S, Fallin MD, Page WF, Reed T, Partin AW, Walsh PC , Platz EA. Letter to the Editor: Re: Obesity and hormone-dependent tumors: cohort and co-twin control studies based on the Swedish twin registry. Int. J. Cancer. 2006;118:785.
  490. Rohrmann S, Fallin MD, Page WF, Reed T, Partin AW, Walsh PC , Platz EA.: Concordance rates and modifiable risk factors for lower urinary tract symptoms in twins. Epidemiology 2006;17:419-427.
  491. Junyan X, Sauvageot J, Ewing CM, Sun J, Wennuan L, Isaacs SD, Wiley KE, Diaz L, Zheng SL, Walsh PC , Isaacs WB. Germline ATBFI mutations and prostate cancer risk. The Prostate 2006;66:1082-1085.
  492. Nielsen ME, Han M, Mangold L, Humphreys E, Walsh PC , Partin AW, Freedland SJ: Black race does not independently predict adverse outcome following radical retropubic Prostatectomy at a tertiary referral center. J Urol. 2006 Aug;176(2):515-9.
  493. Makarov D, Humphreys EB, Mangold LA, Walsh PC , Partin AW, Epstein JI, Freedland SJ: Pathological outcomes and biochemical progression in men with T1c prostate cancer Undergoing radical prostatectomy with prostate specific antigen 2.6 to 4.0 vs 4.1 to 6.0 Ng/ml. J Urol. 2006 Aug;176(2):554-8.
  494. Parsons JK, Partin AW, Walsh PC : Anatomic radical retropubic prostatectomy. In Prostate Cancer Principles and Practice, (eds) Kirby, RS, Partin AW, Feneley M, Parsons JK. Taylor and Francis, London and New York, 2006, pp. 715-732.
  495. Walsh, PC, Partin AW: Radical retropubic prostatectomy. In Campbell-Walsh Urology 9th Edition, (eds) Wein, AJ, Kavoussi, LR, Novick AC, Partin, AW, Peters CA. Saunders Elsevier, Philadelphia, 2007, pp. 2956-2957.
  496. Schaid DJ, McDonnell SK, Zarfas KE, Cunningham JM, Hebbring S, et al. Pooled genome linkage scan of aggressive prostate cancer: results from the International Consortium for Prostate Cancer Genetics. Hum Genet. 2006 Nov;120(4):471-85
  497. Walsh PC . Re: The Prostate Cancer Prevention Trial: design, biases and interpretation of study results. P. J. Goodman, I. M. Thompson, Jr., C. M. Tangen, J. J. Crowley, L. G. Ford and C. A. Coltman, Jr., J Urol, 175: 2234-2242, 2006. J Urol. 2006 Dec;176(6 Pt 1):2744; author reply 2744.
  498. Freedland SJ, Partin AW, Humphreys EB, Mangold LA, Walsh PC . Radical prostatectomy for clinical stages T3a disease. Cancer 2007 Apr 1;109(7):1273-8.
  499. Gudmundsson J, Sulem P, Manolescu A, Amundadottir LT, Gudbjartsson D, et al. Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat Genet. 2007 May;39(5):631-7.
  500. Walsh PC . The discovery of the cavernous nerves and development of nerve sparing radical retropubic prostatectomy. J Urol 2007 May;177(5):1632-5.
  501. Freedland SJ, Humphreys EB, Mangold LA, Eisenberger M, Dorey FJ, Walsh PC , Partin AW. Death in patients with recurrent prostate cancer after radical prostatectomy: prostate-specific antigen doubling time subgroups and associated contributions to all-cause mortality. J Clin Oncol. 2007 May 1;25(13):1765-71.
  502. Camp NJ, Cannon-Albright LA, Farnham JM, Baffoe-Bonnie AB, George A, Powell I, Bailey-Wilson JE, Carpten JD, et al. Compelling evidence for a prostate cancer gene at 22q12.3 by the International Consortium for Prostate Cancer Genetics. Hum Mol Genet. 2007 Jun 1;16(11):1271-8.
  503. Markarov DV, Trock BJ, Humphreys EB, Mangold LA, Walsh PC , Epstein JI, Partin AW. Updated nomogram to predict pathologic stage of prostate cancer given prostate- specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 and 2005. Urology 2007 Jun;69(6):1095-101.
  504. Mohler J, Babaian RJ, Bahnson RR et al. Prostate Cancer. Clinical practice guidelines in oncology. J Natl Compr Canc Netw 2007;5/(7):650.
  505. Magheli A, Rais-Bahrami S, Peck HJ, Walsh PC , et al. Importance of tumor location in patients with high preoperative prostate specific antigen levels (greater than 20 ng/ml) treated with radical prostatectomy. J Urol 2007;178(4 Pt 1): 1311.
  506. Chuang AY, Nielsen ME, Hernandez DJ, Walsh PC , Epstein JI. The significance of positive surgical margin in areas of capsular incision in otherwise organ confined disease at radical prostatectomy. J Urol 2007 178(4 Pt 1):1306.
  507. Zheng SL, Sun J, Cheng Y, Li G, et al. Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans. J Natl Cancer Inst 2007;99(20): 1525.
  508. Carter HB, Ketterman A, Warlick C, et al. Expectant management of prostate cancer with curative intent: an update of the Johns Hopkins experience. J Urol 2007 Dec;178(6):2359-64. Epub 2007 Oct 22.
  509. Duggan D, Zheng SL, Knowlton M, et al. Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP. J Natl Cancer Inst. 2007 Dec 19;99(24):1836-44. Epub 2007 Dec 11.
  510. Walsh PC , DeWeese TL, Eisenberger MA. Clinical practice. Localized prostate cancer. N Engl J Med. 2007 Dec 27;357(26):2696-705.
  511. Makarov DV, Humphreys EB, Mangold LA, et al. The natural history of men treated with deferred androgen deprivation therapy in whom metastatic prostate cancer developed following radical prostatectomy. J Urol. 2008 Jan;179(1):156-61. Epub 2007 Nov 14.
  512. Gudmundsson J, Sulem P, Rafnar T, et al. Common sequence variants on 2pl5 and Xp11.22 confer susceptibility to prostate cancer. Nat Genet. 2008;40(3):281.
  513. Sun J, Lange EM, Isaacs SD, et al. Chromosome 8q24 risk variants in hereditary and non-hereditary prostate cancer patients. 2008 Jan 22 (Epub ahead of print).
  514. Muntener M, Epstein JI, Hernandez DJ, et al. Prognostic significance of Gleason score Discrepancies between needle biopsy and radical prostatectomy. Eur Urol 2008;53(4):767.
  515. Sun J, Purcell L, Gao Z, et al. Association between sequence variants at 17q12 and 17q24.3 and prostate cancer risk in European and African Americans. Prostate 2008;68(7):691.
  516. Loeb S, Hernandez DJ, Mangold LA, et al. Progression after radical prostatectomy for Men in their thirties compared to older men. BJU Int 2008;101(12):1503.
  517. Trock BJ, Han M, Freedland, et al. Prostate cancer-specific survival following salvage Radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy. JAMA 2008;299(23):2760.
  518. Hernandez DJ, Nielsen ME, Han M, et al. Natural history of pathologically organ- Confined (pT2), Gleason score 6 or less, prostate cancer after radical prostatectomy. Urology 2008;72(1):172.
  519. Nielsen ME, Makarov DV, Humphreys E, Mangold L, Partin AW. Is it possible to compare PSA recurrence-free survival after surgery and radiotherapy using revised ASTRO criterion – “nadir + 2”? Urology 2008;72(2):389.
  520. . Nielsen ME, Walsh PC . Reply. Urology 2008;72(2):394.
  521. Walsh PC . Book review. Do no harm: how a magic bullet for prostate cancer became a medical quandary. NEJM 2008;358(23):2526.
  522. Sun J, Chang BL, Isaacs SD, et al. Cumulative effect of five genetic variants on prostate cancer risk in multiple study populations. Prostate 2008;68(12):1257.
  523. Xu J, Isaacs SD, Sun J, et al. Association of prostate cancer risk variants with clinicopathologic characteristics of the disease. Clin Cancer Res 2008;14(18):5819.
  524. Sun J, Zheng SL, Wiklund F, et al. Evidence for two independent prostate cancer risk- associated loci in the HNF1B gene at 17q12. Nat Genet 2008;40(10):1153. Epub Aug 31.
  525. . Loeb S, Ketterman A, Carter HB, Ferrucci L, Metter EJ, Walsh PC . Does prostate cancer growth confound prostate specific antigen velocity? Data from the Baltimore longitudinal study of aging. J Urol 2008 180(4):1314.
  526. Walsh PC . Legends in urology. Perfecting nerve-sparing radical prostatectomy: sailing in uncharted waters. Canadian J Urol 2008;15(15):4230.
  527. Nielsen ME, Schaeffer EM, Marschke P, Walsh PC . High anterior release of the levator Fascia improves sexual function following open radical retropubic prostatectomy. J Urol 2008;180(6):2557.
  528. Walsh PC . Reply. It's time to abandon an upper limit of normal for prostate specific antigen: assessing the risk of prostate cancer: IM Thompson, DP Ankerst, R Etzioni and T Wang. J Urol 2008;180:1219.
  529. Hsu FC, Sun J, Wiklund F, et al. A novel prostate cancer susceptibility locus at 19q13. Cancer Res. 2009 Mar 24, Epub ahead of print.
  530. Loeb S, Schaeffer EM, Chan DW, Carter HB, Walsh PC . Investigation of human anti- mouse antibodies as potential cause of postprostatectomy PSA elevation. Urology 2009;73(5):947.
  531. Walsh PC . 2008 Whitmore Lecture: Radical prostatectomy – where we were and where we are going. Urol Oncol 2009;27(3):246.
  532. Kader AK, Sun J, Isaacs SD, et al. Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patients. Prostate 2009 May 11, Epub ahead of print.
  533. Loeb S, Carter HB, Walsh PC , et al. Single nucleotide polymorphisms and the likelihood of prostate cancer at a given prostate specific antigen level. J Urol 2009 May 16 Epub ahead of print.
  534. Walsh PC . Three considerations before advising 5-alpha reductase inhibitors for chemoprevention. J Clin Oncol 2009 Jun 1 Epub ahead of print.
  535. Xu J, Kibel AS, Hu JJ, et al. Prostate cancer risk associated loci in African Americans. Cancer Epidemiol Biomarkers Prev 2009;18(7):2145. Epub 2009 Jun 23.
  536. Lu L, Sun J, Isaacs SD, et al. Fine-mapping and family-based association analyses of prostate cancer risk variants at Xp11. Cancer Epidemiol Biomarkers Prev 2009;18/(7):2132. Epub 2009 Jun 23.
  537. Loeb S, Ketterman A, Carter HB, Ferrucci L, Metter EJ, Walsh PC . Prostate volume changes over time: results from the Baltimore Longitudinal Study of Aging. J Urol 2009; 182(4):1458. Epub 2009 Aug 15.
  538. Loeb S, Epstein JI, Humphreys EB, Walsh PC . Does perineural invasion on prostate biopsy predict adverse prostatectomy outcomes? BJU Int. 2010;105(11):1510-3. Epub ahead 2009 Aug 19.
  539. Loeb S, Schaeffer EM, Trock BJ, Epstein JI, Humphreys EB, Walsh PC . What are the outcomes of radical prostatectomy for high-risk prostate cancer? Urology 2010 76(3):710-7. Epub 2009 Nov 22.
  540. Walsh PC . PSA cancer screening, much like a seat belt, is a wise choice for men. US News and World Rep 2009;146(11):18.
  541. Xu J, Zheng SL, Isaacs SD, et al. Inherited genetic variant predisposes to aggressive but not indolent prostate cancer. Proc Natl Acad Sci USA 2010;107(5):2136. Epub 2010 Jan 11.
  542. Nielsen ME, Trock BJ, Walsh PC . Salvage or adjuvant radiation therapy: counseling patients on the benefits. J Natl Compr Canc Netw 2010;8(2):228. Review.
  543. Schaeffer EM, Loeb S, Walsh PC . The case for open radical prostatectomy. Urol Clin North Am 2010;37(1):49.
  544. Pierorazio PM, Humphreys E, Walsh PC , Partin AW, Han M. Radical prostatectomy in older men: survival outcomes in septuagenarians and octogenarians. BJU Int 2010 Mar 1 Epub ahead of print.
  545. Christiensen GB, Baffoe-Bonnie AB, George A, et al. Genome-wide linkage analysis of 1,233 prostate cancer pedigrees from the International Consortium for Prostate Cancer Genetics using novel sumLINK and sumLOD analyses. Prostate 2010;70(7):735.
  546. Pierorazio PM, Guzzo TJ, Han M, et al. Long-term survival after radical prostatectomy for men with high Gleason sum in pathologic specimen. Urology 2010 Mar 27 Epub ahead of print.
  547. Walsh PC . Chemoprevention of prostate cancer. N Engl J Med 2010;362(13):1237.
  548. Trock BJ, Walsh PC . Re: Radiation therapy after radical prostatectomy: impact on metastasis and survival S.A. B oorjian, R.J. Karnes, P.L. Crispen et al. J Urol 2009;182:2708. J Urol 2010;183(6):2466.
  549. Ross AE, Loeb S, Landis P, et al. Prostate-specific antigen kinetics during follow-up are an unreliable trigger for intervention in a prostate cancer surveillance program. J Clin Oncol 2010;28(17):2810. Epub 2010 May 3.
  550. Loeb S, Markarov DV, Schaeffer EM, Humphreys EB, Walsh PC . Prostate specific antigen at the initial diagnosis of metastasis to bone in patients after radical prostatectomy. J Urol 2010;184(1):157 Epub 2010 May 16.
  551. Han M, Trock BJ, Partin AW, et al. The impact of preoperative erectile dysfunction on survival after radical prostatectomy. BJU Int 2010; Jun 29 Epub ahead of print.
  552. Roberts WB, Tseng K, Walsh PC , Han M. Critical appraisal of management of rectal injury during radical prostatectomy. Urology 2010 Jun 18 Epub ahead of print.
  553. Trock BJ, Walsh PC . Impact of postoperative prostate-specific antigen disease recurrence and the use of salvage therapy on the risk of death. Cancer 2010 Oct 4. Epub ahead of print.
  554. Ye H, Walsh PC , Epstein JI. Skeletal muscle involvement by limited Gleason score 6 Adenocarcinoma of the prostate on needle biopsy is not associated with adverse findings at radical prostatectomy. J Urol 2010;184(6):2308. Epub 2010 Oct 16.
  555. Pierorazio PM, Epstein JI, Humphreys E, Han M, Walsh PC , Partin AW. The significance of a positive bladder neck margin after radical prostatectomy: The American Joint Committee on Cancer Pathological Stage T4 designation is not warranted. J Urol 2010;183(1):151-7. Epub
  556. Eggener SE, Scardino PT, Walsh PC , et al. Predicting 15-year prostate cancer specific mortality after radical prostatectomy. J Urol 2011;185(3):869.
  557. Joshu CE, Mondul AM, Menke A, et al. Weight gain is associated with an increased risk of prostate cancer recurrence after prostatectomy in the PSA era. Cancer Prev Res 2011;4(4):544.
  558. Mondul AM, Han M, Humphreys ED, Meinhold CL, Walsh PC , Platz EA. Association of statin use with pathological tumor characteristics and prostate cancer recurrence after surgery. J Urol 2011; 185(4):1268.
  559. Pierorazio PM, Rose AE, Schaeffer EM, et al. A contemporary analysis of outcomes of adenocarcinoma of the prostate with seminal vesicle invasion (pT3b) after radical prostatectomy. J Urol 2011; Mar 16 Epub ahead of print
  560. Tosoian JJ, Trock BJ, Landis P, et al. Active surveillance program for prostate cancer: an update of the Johns Hopkins experience. J Clin Oncol 2011 Apr 4 Epub ahead of print.
  561. Joshu CE, Mondul AM, Meinhold CL, et al. Cigarette smoking and prostate cancer recurrence after prostatectomy. J Natl Cancer Inst 2011 Apr 15 Epub ahead of print
  562. Loeb S, Feng Z, Ross A, Trock BJ, Humphreys EB, Walsh PC . Can we stop prostate specific antigen testing 10 years after prostatectomy? J Urol 2011;186(2):500. Epub 2011 Jun 15.
  563. Toubaji A, Albadine R, Meeker AK, et al. Increased gene copy number of ERG on chromosome 21 but not TMPRSS2-ERG fusion predicts outcome in prostatic adenocarcinomas. Mod Pathol 2011;24(11):1511. Epub 2011 Jul 8.
  564. Lu L, Cancel-Tassin G, Valeri A, et al. Chromosomes 4 and 8 implicated in a genome- wide SNP linkage scan of 762 prostate cancer families collected by the ICPCG. doi: 10.1002/pros.21443. Epub 2011 Jul 11.
  565. Antonarkis ES, Feng Z, Trock BJ. The natural history of metastatic progression in men with prostate-specific antigen recurrence after radical prostatectomy: long-term follow up. Doi: 10.1111/j.1464-410X.2011.10422.x. Epub 2011 Jul 20.
  566. Jin G, Lu L, Cooney KA, et al. Validation of prostate cancer risk-related loci identified from genome-wide association studies using family-based association analysis: evidence from the International Consortium for Prostate Cancer Genetics (ICPCG). Hum Genet 2011 Dec 25 Epub ahead of print.
  567. Ewing CM, Ray AM, Lange EM, et al. Germline mutations in HOXB13 and prostate cancer risk. N Engl J Med 2012;366(2):141.
  568. Ross AE, Feng Z, Pierorazio PM, et al. Effect of treatment with 5-α reductase inhibitors on progression in monitored men with favourable-risk prostate cancer. BJU Int. 2012; doi:10.1111/j.1464-410X.2011.10875.x. Epub ahead of print.
  569. Pierorazio PM, Ross AE, Lin BM, et al. Preoperative characteristics of high-Gleason disease predictive of favourable pathological and clinical outcomes at radical prostatectomy. BJU Int. 2012 doi: 10.1111/j.1464-410X.2012.10986.x. Epub ahead of print.
  570. Sutcliffe S, Pakpahan R, Sokoll LJ, et al. Prostate-specific antigen concentration in young men: new estimates and review of the literature. BJU Int 2012 Epub ahead of print.
  571. Walsh PC . How Charles Huggins made his nobel prize winning discovery – in his own words: An historic audio recording. Prostate 2012 doi: 10.1002/pros.22524
  572. Kaye DR, Walsh PC , Netto GJ. Gonzalez-Roibon N, Rodriguez R. A 66-year-old man with prostate-specific antigen recurrence and lung mass after radical prostatectomy. Urology 2012;80(2):247.
  573. Bailey-Wilson JE, Childs EJ, Cropp CD, et al. Analysis of Xq27-28 linkage in the international consortium for prostate cancer genetics (ICPCG) families. BMC Med Genet. 2012;13(1):46.
  574. Chalfin HJ, Dinizo M, Trock BJ, et al. Impact of surgical margin status on prostate- cancer-specific mortality. BJU Int 2012 doi:10.1111/j.1464-410X.2012.11371.x. Epub ahead of print.
  575. Catalona WJ, D'Amico AV, Fitzgibbons WF, et al. What the U.S. Preventive Services Task Force missed in its prostate cancer screening recommendation. Ann Intern Med. 2012 157(2):137.
  576. Eifler JB, Feng Z, Lin BM, et al. An updated prostate cancer staging nomogram (Partin tables) based on cases from 2006 to 2011. BJU Int 2012 doi:10.1111/j.1464- 410X.2012.11324.x. Epub ahead of print

 

BOOKS

 

  1. Male Infertility (eds) Richard D. Amelar, Lawrence Dubin, Patrick C. Walsh. W.B. Saunders, 1977.
  2. Campbell's Urology Fourth Edition (eds) J.H. Harrison, R.E. Gittes, A.D. Perlmutter, T.A. Stamey, P.C. Walsh. W.B. Saunders, 1978.
  3. Campbell's Urology Fifth Edition (eds) P.C. Walsh, R.E. Gittes, A.D. Perlmutter, T.A., Stamey. W.B. Saunders, 1986.
  4. Campbell's Urology, Sixth Edition (eds) P.C. Walsh, A.B. Retik, T.A. Stamey, E.D. Vaughan, Jr., W.B. Saunders, 1992.
  5. The Prostate: A Guide for Men and the Women Who Love Them. P.C. Walsh, J.F. Worthington. Johns Hopkins Press, 1995.
  6. Campbell's Urology Seventh Edition (eds) P.C. Walsh, A.B. Retik, Wein, A., E.D. Vaughan, Jr. W.B. Saunders, 1997.
  7. Dr. Patrick Walsh's Guide to Surviving Prostate Cancer. P.C. Walsh, J.F. Worthington. Warner Books, 2001.
  8. Dr. Patrick Walsh's Guide to Surviving Prostate Cancer, Second Edition. P.C. Walsh, J.F. Worthington. Warner Wellness, 2007. MOTION
  9. Dr. Patrick Walsh's Guide to Surviving Prostate Cancer, Third Edition. P.C. Walsh, J.F. Worthington. Hachette Book Group, 2012.

 

PICTURES/VIDEO PRESENTATIONS

 

  1. Kaufman, J.J., Walsh, P.C.: The Art of Retropubic Prostatectomy. American Urological Association Film Library, 1969.
  2. Kaufman, J.J., Walsh, P.C.: Visits in Urology - Renal Revascularization for Hypertension. American Urological Association Film Library, 1984.
  3. Walsh, P.C.: Radical Retropubic Prostatectomy and Cystoprostatetctomy: Surgical Technique for Preservation of Sexual Function. American Urological Association Film Library, 1985.
  4. Schlegel, P.N. and Walsh, P.C.: Radical cystectomy with preservation of sexual function ‘Neuroanatomical considerations and surgical technique', American Urological Association Film Library, 1987.
  5. Walsh, P.C.: Radical retropubic prostatectomy with preservation of sexual function - An update after 500 cases. Aegis Productions, Inc., New York, NY 1987.
  6. Walsh, P.C., Burnett, A.L., and Partin, A.W.: Radical Retropubic Prostatectomy: Evolution of the Surgical Technique. Distributed by GD Searle and Co., 1993.
  7. Walsh, P.C., & Schroder, F.H.: Radical Prostatectomy, Simultaneous Demonstrations by Patrick C. Walsh, M.D. and Fritz H. Schroder, M.D. Distributed by Roussel Pharmaceuticals, 1993.
  8. Alpha Omega Alpha Leaders in American Medicine.
  9. Walsh, P.C., Garcia, J.R., Jr., Radical Retropubic Prostatectomy: A Detailed Description of the Surgical Technique, DVD 2004. http://urology.jhu.edu/
U.S. News and World Report Rankings Badge

 

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.| Disclaimer
Email: webmaster@urology.jhu.edu | 600 North Wolfe Street, Baltimore, Maryland 21287